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1. ABSTRACT 
In eukaryotes the genetic information is stored in chromatin, a highly structured 
nucleoprotein complex that mediates the coordinated regulation of gene expression. The 
basic unit of chromatin is the nucleosome, which consists of 147bp of DNA wound around 
a histone octamer core containing two copies of the histones H2A, H2B, H3 and H4. 
Changes in chromatin structure, which do not involve the nucleotide sequence, can 
translate into transient or heritable adjustments in gene expression. Various mechanisms 
modulate chromatin states: among them a pivotal role is played by covalent histone post-
translational modifications (hPTMs), for which the repertoires of combinations and 
positions are extremely varied. In addition to hPTM patterns, chromatin is characterized by 
the local enrichment of a distinct set of histone variants; binding proteins, including 
various ATP-dependent chromatin remodelling complexes; DNA methylation and 
differential nucleosome density. Together, these components contribute to the 
establishment of specific “chromatin landscapes”, defining the functional state of the 
genome in that territory. 
Chromatin immunoprecipitation (ChIP) and Mass Spectrometry (MS) are 
complementary strategies to investigate the epigenetic components of chromatin. ChIP 
followed by deep sequencing (ChIP-Seq) allows genome-wide profiling of hPTMs and 
binders at individual genes and regulatory regions, up to a resolution of inividual 
nucleosomes. However, ChIP does not inform about the protein portion of chromatin, 
knowledge instead offered by MS-based proteomics. At the level of individual histones, 
MS enables to detect virtually all hPTMs in an unambiguous and unbiased fashion and to 
reveal interplays between them. Yet, MS analysis on bulk chromatin preparations limits the 
inspection of PTMs to a global view, with no information about their patterning in distinct 
functional regions. Nowadays, a global investigation of synergies between histone PTMs, 
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variants, and chromatin-associated proteins in a locus-specific manner remains a very 
attractive unachieved goal. 
During the course of my PhD, I contributed in this direction developing and 
optimizing a global, quantitative proteomic strategy, named ChroP (Chromatin 
Proteomics), for the analysis of the protein component of distinct chromatin regions, 
enriched by modified and preparative version of ChIP. I developed two ChroP protocols, 
which differ in the step of chromatin IP:  the Native-ChIP (N-ChIP) was used to dissect 
histone PTM patterns whereas the Crosslinking ChIP (X-ChIP) was used in combination 
with SILAC-based interactomics to characterize proteins interacting with the domains of 
interest. I used the antibodies against tri-methylated Lysine 9 and Lysine 4 on histone H3 
(H3K9me3 and H3K4me3) to enrich functionally distinct and non-overlapping chromatin 
regions from HeLa nuclei. High-resolution MS of the fractionated nucleosomes enabled a 
dissection of the domain-specific composition in terms of histone modifications, variants 
and non-histonic proteins, which we refer to as the modificome and interactome.  
First of all, I observed the expected combinatorial enrichment of silent 
modifications in H3K9me3, and of active ones in H3K4me3. The accordance of my results 
with previous studies allows to validate the robustness of the approach and, with this 
confidence, I could investigate novel PTMs. Remarkably, ChroP exhibited a unique and 
peculiar strength in revealing PTMs associations not only at the intra-molecular level 
within H3, but also across the different core histones, within the same nucleosome. 
The SILAC-based investigation of co-associated proteins revealed a number of 
histone variants and multi-protein complexes differentially enriched in the two functional 
territories. Some of them confirmed several previously described interactions, thereby 
validating our method. In addition, I identified numerous novel interactors, suggesting 
potential novel roles and regulating chromatin pathways for these proteins. A 
representative case was the variant H2A.X with the WICH chromatin-remodeling complex, 
accumulating in the H3K9me3 regions. I thus propose a higher local density model for 
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H2A.X in heterochromatin and provide evidence that this accumulation, together with the 
recruitment of WICH, represents an additional level of modulation of the DNA damage 
response (DDR) in this chromatin compartment. 
 The ChroP approach is relatively easy to setup, given the limited changes made to 
the conventional N- and X- ChIP protocols. Hence, ChroP emerges as a potential useful 
tool to dissect chromatin composition and understand how all the distinct protein 
components can act in a concerted manner to enforce a specific chromatin status.  
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2. INTRODUCTION 
2.1  Chromatin, epigenetics and histone post-translational modifications 
Chromatin is a highly ordered nucleoprotein complex that mediates both the DNA 
compaction into the eukaryotic nucleus and the regulation of gene expression. At the 
structural level, the basic unit of chromatin is the nucleosome, consisting of 147bp of DNA 
wound around an octamer core containing one histone H3-H4 tetramer and two histone 
H2A-H2B dimers (1, 2). Functionally, chromatin is organized into two distinct regions: 
euchromatin is less condensed and generally permissive for transcription, whereas 
heterochromatin is highly condensed and transcriptionally silent. Heterochromatin is 
classified as being either constitutive or facultative. In constitutive heterochromatin, the 
DNA remains condensed throughout the cell cycle. In facultative heterochromatin however 
the DNA can loose its condensed form and become transcriptionally active in response to 
distinct signals (3-5). 
Changes in chromatin structure that do not involve the nucleotide sequence can 
translate into heritable adjustments of gene expression and thus constitute an “epigenetic 
memory” system of the cell (6-10). Epigenetic inheritance can be explained through a step-
wise model proposing that “epigenator, initiator and maintainer” factors operate 
sequentially and synergistically to enforce and maintain specific functional states of the 
genome (11). The “epigenator”, a signal emanating from the external environment, is 
translated by an “initiator” into a specific chromatin/DNA functional state, which is 
sustained by a number of different “maintainer” factors. These include the methylation of 
cytosine in CpG islands (12, 13), covalent post-translational modifications of histones 
(hPTMs) and, in light of more recent studies, the activities of non-coding RNAs (ncRNA) 
(14, 15).  
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Among the epigenetic maintainers listed, histone PTMs are largely recognized as 
key regulators of chromatin structure and function. hPTMs include acetylation, 
ubiquitination and sumoylation of Lysines; different methylation degrees of Arginines and 
Lysines; phosphorylation of Serines, Threonines and Tyrosines; ADP-ribosylation of 
Arginines, Glutamic and Aspartic acids; deimination (or citrullination) of Arginine; Proline 
isomerization (Figure 1) (16-18), and in addition some less-characterized modifications. 
 
Figure 1. Histone post-translational modifications. The nucleosome core particle, with 
the N-terminal tail of core histone and the annotation of sites of post-translational 
modification. Numbers along the DNA indicate each complete helical turn on either side of 
the dyad axis. Sites marked by green arrows are susceptible to cutting by trypsin in intact 
nucleosomes. Most important modifications are Acetyl Lysine (acK); methyl Lysine 
(meK); methyl arginine (meR); phosphoryl serine (PS); ubiquitinated lysine (uK). Adapted 
from Bennister A.J. and Kouzarides T. Cell Res 2011. 
 
                                 
 
The histone code hypothesis proposes that histone post-translational modifications act 
either singly or in combination to control distinct downstream pathways or processes on 
chromatin, ultimately defining the functional status of the underling DNA (19). The 
“letters” of this code are the modifications themselves, which are placed and removed by 
enzymes known as “writers” and “erasers”, respectively. hPTMs exert their function on 
chromatin through two distinct mechanisms. In the first, higher orders of chromatin 
structure are altered via changes in inter-nucleosomal or histone-DNA interactions, thus 
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controlling the accessibility of DNA-binding proteins such as transcription factors (cis 
mechanisms). Alternatively, hPTMs can generate binding platforms for the recruitment of 
effector proteins containing specialized domains (trans mechanisms): the so-called 
“readers” of the code (Figure 2). The “readers” translate the information encoded by the 
modification patterns into specific biological outcomes (20-23). 
 
Figure 2. Domains binding modified histones. Representation of some proteins with 
specific domains able to specifically bind modified histones. Adapted from Kouzarides T. Cell 
2007. 
 
 
                
 
In addition to hPTM patterns, chromatin is characterized by the local enrichment of a 
distinct set of histone variants; binding proteins, including various ATP-dependent 
chromatin remodelling complexes; and differential nucleosome density and position. 
Together, these components contribute to the establishment of specific “chromatin 
landscapes”, defining the functional state of the genome in that territory (Figure 3) (24). 
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Figure 3. The distinct components contributing to define the functional state of 
chromatin domain. Adapted from Margueron R. and Reinberg D. Nat Rev Genet 2010.  
 
 
 
 
 
Antibodies directed against specific hPTMs are traditionally used to study the language of 
histone modification in various assays. These include: immunofluorescence (IF) analyses 
of modifications at the single cell level; immunoblotting (WB), which allows profiling of 
PTMs in different samples and/or conditions; as well as chromatin immunoprecipitation 
(ChIP), which can be coupled to either PCR, DNA microarray (ChIP-on-chip) or deep 
sequencing (ChIP-Seq) for description of their local enrichments. The last two methods 
allow the genome-wide mapping of modifications, with a resolution of a few nucleosomes 
(25-27). Antibody-based assays are hampered by limitations in their specificity and 
efficiency when used to reveal the combinatorial aspect of the code. In fact, modifications 
can occur on adjacent or closely spaced residues within the same histone, making an 
epitope-masking effect more likely. To address this issue, a number of strategies have been 
developed to assess accurately the specificity of antibodies used in chromatin research. 
Peach et al. combine immunoprecipitation (IP) of native HPLC-purified H3 with mass 
spectrometry to detect PTMs co-enriched by a certain antibody on the same polypeptide. In 
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addition, Fuchs et al. have developed a peptide-array assay, based on a comprehensive 
library of modified peptides (28, 29).  
Mass spectrometry (MS) has emerged as a promising complementary analytical 
strategy to identify known and novel PTMs on proteins, as well as for the relative 
quantitation and detection of interactions between them (30). The recent advent of high-
resolution mass spectrometry has increased the relevance of MS-based hPTM analysis by 
enabling the discrimination of near-isobaric modifications, either singly or in 
combinations, on very long polypeptides and even on intact histones (31-39). Finally, the 
use of different labeling strategies, both chemical and metabolic, has enabled the accurate 
quantitation of modifications, both in a relative and absolute manner (40).  
The “epigenomics” and “chromatomics” fields share a common goal in studying 
chromatin structure, composition and features: to gain a comprehensive view, from 
genome to proteome, of the epigenetic phenomena underlying the establishment and 
inheritance of specific expression patterns (41, 42).  
2.2 Mass Spectrometry analysis and MS based-proteomics  
The steps of a typical proteomic experiment are shown in Figure 4. Briefly, after 
reducing the complexity of a protein preparation by electrophoretic speparation the 
proteins are subjected to enzymatic digestion, tipically using trypsin as protease. After MS 
analysis, by which the MS informations at the peptide level are obtained, the specific 
proteins are identified by software-assisted database searching, with which it is also 
possible to identify and localize PTMs within the peptide. 
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Figure 4. Proteomics experiment overview. A protein mixture is prepared from a 
biological sample and separated by SDS–PAGE. The generated peptides are separated by 
HPLC. Peptides are then ionized then analyzed by different mass spectrometers. Finally, 
the peptide-sequencing data that are obtained from the mass spectra are searched against 
protein databases using one of a number of database-searching programs.  
 
 
 
Generally, the classical proteomic workflow for proteins identification is also applicable to 
the analysis of PTMs, although the analysis is inherently more difficult than simple 
protein/peptide identification for the following reasons: 
1. PTMs of proteins are typically of low abundance. Hence high sensitivity of detection 
is required to identify the PTM and to assign its position within the peptide sequence. 
 2. PTMs are frequently labile: sometimes is difficult to maintain the peptide in its 
modified state during sample preparation and subsequent ionization in the mass 
spectrometer, since the covalent bond between the PTM and amino acid side chain in the 
peptide is typically labile.  
Before describing in detail the different MS approaches applied to in-depth investigation of 
histones and their PTMs, as well as non-histonic chromatin proteins, it is first necessary to 
provide an overview of the basic principles of mass spectrometry (43, 44). 
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2.2.1 Basic concepts of Mass Spectrometry 
The mass spectrometer is a multistage instrument that measure the mass-to-charge 
ratio (m/z) of freely moving gas-phase ions in electric and/or magnetic fields. The 
elemental composition of the peptide can then be derived from his m/z ratio, whereas 
direct information about amino acid sequence cannot be deduced from m/z alone. To this 
aim, the desired peptide ion (precursor) needs first to be isolated and then fragmented, by a 
second cycle of MS, into its constituent amino acids. The fragments can be revealed in the 
MS/MS spectrum, providing unambiguous identification of the peptide sequence. 
Importantly, MS/MS enables the precise localization of modifications present on specific 
residues (45). A mass spectrometer consists of three main parts (Figure 5): 
1. an ion source: it converts the peptides into gas-phase ions. 
2. a mass analyzer: it separates the ions according to their mass/charge ratio (m/z).  
3. a detector: it records the number of ions at each m/z value. 
 
Figure 5. Schematic representation of the basic components of a mass spectrometer. 
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1. Ion Source and ionization of peptides 
Proteins and peptides are polar, nonvolatile species that require an ionization 
method to transfer them into the gas phase, without extensive degradation. One of the most 
important developments in instrumentation has been the introduction of “soft-ionization” 
technology, which permits proteins and peptides to be analyzed by MS. Two techniques 
paved the way for the modern bench-top MS proteomics: Matrix-assisted laser desorption 
ionization (MALDI) (46, 47), and Electrospray ionization (ESI) (48). In a MALDI source, 
peptides are co-crystallized with a solid-phase matrix onto a metal plate. The matrix 
typically consists of a small organic molecule such as α-cyano-4-hydroxycinnamic acid or 
dihydrobenzoic acid (DHB). When laser pulses irradiate the resulting solid mixture, this 
absorbs the laser energy and transfers it to the acidified peptides. At the same time, the 
rapid heating causes desorption of both matrix and newly formed [M+H]+ protonated 
peptides into the gas phase. Currently, MALDI ionization can support different types of 
mass analyzers, but the most common combination for proteomics studies is the 
MALDI/time-of-flight (TOF) setup (49). In recent mass analyzers, ions generated in the 
source are accelerated to a fixed amount of kinetic energy and travel down a flight tube. 
The small ions have a higher velocity and are recorded by a detector before the larger ones. 
The m/z value displayed in a TOF spectrum is proportional to the time, for a given analyte, 
required to reach the detector. Unlike MALDI, the ESI source produces ions from the 
solution. Peptides exist as ions in solution because they contain functional groups whose 
ionization is controlled by the pH of the solution. At acidic pH values, protonation of the 
amines will confer overall net positive charge to peptides and proteins, while at basic pH, 
de-protonation of the amines and carboxyl groups confers a more negative overall charge. 
Fragmentation of peptide ions is favored by positive charges on the peptide ions. For these 
reasons, ESI of peptides is most commonly done in the positive ion mode to analyze acidic 
samples.  
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Briefly, the ESI process consists of the formation of an electrically charged spray 
(Figure 6), driven by high voltage (2–6 kV), which then drives the desolvation of 
peptide/protein-solvent droplets. This process is aided by the high temperature provided by 
a heated capillary and, in some cases, by sheath gas flow at the mass spectrometer inlet. 
There are different theoretical models to describe ESI ion formation, however the 
important features are: formation of multiply charged species; sensitivity to analyte 
concentration and flow rate.  
 
Figure 6. The process of electrospary ionization (ESI). The charged liquid exits the tip 
and forms a cone shape (known as a Taylor cone). After, the droplets burst away from each 
other into a fine spray. 
                                                           
  
Tipically, liquid chromatography (LC) instruments are usually coupled “on-line” with the 
ESI source to achieve continuous or high throughput analysis (Figure 7). After ionization, 
the peptide ions pass from the source into the mass analyzer where the ions are then 
separated in according to their mass/charge ratio.  
 
Figure 7. Liquid chromatography directly coupled to the mass spectrometry (nanoLC-
MS). After separation on a reverse-phase C18 nano-column, eluting peptides are directly 
electro-sprayed into the mass spectrometer. 
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2. Mass Analyzer (and tandem mass analysis) 
The mass analyzer is the heart of the instrument. Several types of tandem mass 
analyzers are commonly paired with ESI sources for proteomics work. These are: time of 
flight (TOF), quadrupole (Q), ion trap, orbitrap (OT) and Fourier transform-ion cyclotron 
resonance (FT-ICR). Although these mass analyzers differ in the details of how they work, 
they all perform the same type of analysis. From a mixture of peptide ions generated by the 
ion source, the tandem MS analyzers select a single m/z species. Collision-induced 
dissociation (CID) has been the most widely used MS/MS technique in proteomics 
research (50). Briefly, gas-phase peptide/protein cations are internally heated by multiple 
collisions with rare gas atoms. This leads to breakage of the C-N bond in the peptide 
backbone, resulting in a series of characteristic ions (b- and y- fragment ions). As a result 
of the slow-heating energetic aspect of this method, internal fragmentation and neutral-
losses of water, ammonia and labile PTMs are common. This often results in limited 
sequence information for large peptides (>15 amino acids) and intact proteins.  
This limitation has been addressed by the development of novel methods for ion-
electron reactions to carry out peptide fragmentation: electron capture dissociation (ECD) 
and electron transfer dissociation (ETD) enable sequencing of larger peptides, providing an 
option to investigate combinatorial features of hPTMs (51-54). Both ECD and ETD are 
based on the transfer of electrons to the multi-protonated longer peptides (>2 kDa). In 
ECD, the electrons are generated from a heated filament, whereas in ETD they are 
transferred by gas-phase radical ions. Despite the similarity between the two techniques, 
ECD can be used only in combination with Fourier transform ion cyclotron resonance (FT-
ICR) instruments, whereas ETD can be implemented in low-cost, high-capacity ion traps 
or new generation Orbitrap mass spectrometers and it has thus a wider applicability. The 
information contained in this tandem or MS-MS spectrum permits the sequence of the 
peptide to be deduced. Moreover, the nature and sequence location of peptide modification 
also can be established from an MS-MS spectrum (Figure 8). 
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Figure 8. Example of collision-induced dissociation (CID) MS/MS spectra. 
Representative MS/MS spectra using CID fragmentation. The b-ion and y-ion series allow 
to define the sequence of (9-17) peptide of histone H3 and to localize specifically the di-
methylation on K9 residue.   
 
                                                       
3. Detector 
A detector, as “Channeltron” or “Electron multiplier tubes (EMT)”, is placed at the 
end of MS to record the number of ions at each m/z value. “Channeltron” is a dynode 
coated with semiconductor material. The ions that strike the inner walls cause the emission 
of electrons, which are recorded in a counting system. “EMT” consists in a series of 
dynodes that cause the same effect of “Channeltron”, but it is able to amplify the signal of 
electric current until it is quantifiable. The final output is represented by data.RAW file. 
 
Modern mass spectrometers provide high-quality data in combination with high 
MS/MS sequencing speed. Moreover, the mass spectrometric resolution (a dimensionless 
number calculated by dividing the width of a peak by its mass) and the “dynamic range” 
(the ratio of the strongest signal to the weakest signal that can still be detected in a 
spectrum) represent other two key parameters. Nowadays, most mass spectrometers are so-
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called hybrid instruments because they consist of a combination of two or more m/z 
separation devices of different types. Usually, they are built either as a combination of a 
quadruple mass filter and a time-of-flight analyzer, or as a combination of a linear ion trap 
and an Orbitrap analyzer. Both types of hybrid instruments offer sequencing speeds of 
several MS/MS spectra per second. Orbitrap analyzers are based on frequency detection 
and offer routine resolution of more than 50000 with matching mass accuracy. The 
dynamic ranges in single spectra are in the range of 1000 to 10000 for both types of 
instrument. A very recent linear ion trap Orbitrap instrument (LTQ-Orbitrap Velos) allows 
cycles of one MS followed by 20 MS/MS events in only 2.5 s. It is also routinely capable 
of recording MS/MS spectra at high resolution either by CID or by “higher-energy 
collisional dissociation” (HCD) methods (55).  
In the most common well-established analytical workflow, peptides are resolved 
over time via Reversed-Phase liquid chromatography (RP-LC) prior to MS analysis to 
achieve continuous or high throughput analysis. Tipically, peptide samples are separated 
based on their hydrophobicity using a long capillary column with a typical flow of ~200 
nL/min (nanoflow). The column is packed with C-18 resin to capture the majority of the 
peptides that are loaded in acidified aqueous solution. A gradient of organic solvent 
(acetonitrile, ACN, usually) gradually elute the peptides, which are injected and analyzed 
by the mass spectrometers. For instance, Reverse Phase High-pressure Liquid 
Chromatography (RP-HPLC) has been widely adopted in proteomics to resolve very 
complex peptide mixtures prior to MS analysis (LC-MS), due to its high resolution, 
efficiency, reproducibility, and mobile phase compatibility with ESI. A further 
development of this technology is nano-ESI (56, 57), in which the flow rates are lowered 
to a nanoliter-per-minute regime to improve the method’s sensitivity. Nano-ESI is 
compatible with capillary RP-HPLC columns (58) which allow users to perform higher 
sensitivity analyses than has been possible with standard analytical methods (59).  
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2.2.2 Different MS approaches for hPTMs analysis: from “Bottom Up” to “Top Down”, via 
“Middle Down” 
The “Bottom Up” approach is highly popular in proteomics studies for 
investigations of protein PTMs (30). It is a “peptide-centric” strategy, based on the 
enzymatic digestion of proteins into peptides prior to MS analysis (Figure 9). The “Bottom 
Up” approach has been demonstrated to detect known and novel modifications on histones, 
combining its sensitivity in detecting peptide m/z in full MS with its efficient MS/MS 
fragmentation via CID (31). The most common protease used in bottom up proteomics 
studies is trypsin, which cleaves at the C-terminal end of Arginine and Lysine residues 
(60). However, trypsin digestion is not ideal for the analysis of histones that are highly rich 
in these basic residues (expecially at the N-terminal regions, where the modifications 
accumulate), because the peptides produced are too short to be efficiently retained and 
separated in RP-HPLC and detected by mass spectrometer (61). Arg-C is a good 
alternative because of its unique specificity for the C-terminal region of Arginines, which 
produces peptides of optimal length for LC-MS, which are longer and easy-to-ionize (61, 
62). In addition, Arg-C peptides are compatible for sequencing, as the C-terminal Arginine 
retains a positive charge, leading to a well-defined y-ion series (63-65). Alternatively, 
histones can be chemically derivatized using either propionic anhydride [(C3H5O)2O] or 
deuterated acetic anhydride (D6-acetic anhydride [(CD3CO)2O]), prior to trypsin 
digestion: these compounds alkylate Lysine residues preventing tryptic cleavages and 
resulting in an Arg-C-like digestion. The advantage of this approach is that it is possible to 
obtain the previously described benefits of an Arg-C-like digestion while using trypsin as 
the protease, which is well suited to in-gel digestion methods (66). The in-gel approach, 
commonly performed by SDS-PAGE, facilitates separation at the level of individual 
histone molecules (67). 
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An additional effect of derivatization is that it labels unmodified and mono-methylated 
Lysines with a deuterated acetyl moiety (showing a delta mass of 45.0294 Da) but does not 
react with di-methyl, tri-methyl and acetyl Lysines. This effect can be exploited to 
distinguish between isobaric modification-bearing peptides. 
A limitation of the “Bottom Up” approach emerges when analyzing histone variants 
or combinations of histone modifications. In fact, the short tryptic and Arg-C-like peptides 
do not permit detection of simultaneously occurring, long-distance PTMs. Offline 
chromatography, to separate histone variants or differently modified versions of the same 
histone molecule prior to “Bottom Up” analysis, is one solution to this problem. For 
instance, the three mammalian variants of histone H3 (H3.1, H3.2 and H3.3) have the vast 
majority of their peptides in common after enzymatic digestion but the full-length proteins 
can be separated prior to digestion and LC-MS analysis using tap-tag purifications and/or 
RP-HPLC (68, 69). Alternatively, intact proteins or larger histone domains can be analyzed 
by mass spectrometry with the so-called “Top Down” and “Middle Down” strategies 
(Figure 9) (70, 71). Histones are basic proteins and, in the acidic conditions used in MS, 
they are typically highly charged and capable of producing multiply charged fragment ions 
in MS/MS. Consequently, non-ergodic fragmentation methods (72) such as ETD and ECD 
on high-resolution instruments (Orbitrap, FT-ICR) are feasible in “Top Down” analysis 
(53, 54). “Top Down” enables the user to distinguish between co-occurring histone 
variants and differently modified isoforms, with information about the relative abundances, 
thus providing a so-called “bird’s eye view” on the complete panel of histone isoforms 
present in a specific functional state (73). The approach however lacks the sensitivity of 
“Bottom Up” and, furthermore, the analysis of the spectra obtained is less straightforward. 
These two restraints have limited a broad application of this method so far, even though 
recent advances in online separation of intact proteins by ultra high-pressure (UPLC) liquid 
chromatography have made the approach more feasible. Further improvements in 
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implementations are therefore still required to make “Top Down” analysis of intact 
histones, with variants and modified forms, a more routine approach (74, 75).  
The “Middle Down” approach is an optimal compromise between “Top Down” and 
“Bottom Up” approaches, when the mass spectrometer is hyphenated to online liquid 
chromatography. In “Middle Down” approach, large histone peptides (>2 kDa) are 
analyzed upon the enzymatic digestion of histones with endoproteinases that have 
specificities to less frequently-occurring amino acids within histone sequences, such as 
Glu-C or Asp-N.  In fact, since mammalian H3 contains the first Glutamic acid at position 
50, Glu-C produces an N-terminal peptide (1-50) of 6 kDa that contains the majority of 
PTMs decorating this histone, as well as being suitable for MS analysis and sequencing by 
ETD MS/MS fragmentation. Similarly, Asp-N is useful for “Middle Down” analysis of 
histone H4, because it cleaves at the N-terminal side of Aspartic acid, present in position 
24. Again, the resulting peptide (1-24) includes all modifications annotated for the H4 tail 
(32). The “Middle Down” approach therefore allows a more precise detection of PTM 
combinations on particular histone regions, especially when combined with pre-
fractionation of the enzymatic digestion products. For instance, a combination of weak-
cation exchange with hydrophilic interaction liquid chromatography (WCX-HILIC) prior 
to high-resolution MS, is a powerful analytical setup to resolve co-occurring and/or (near-) 
isobaric modified histone species (76), separating longer peptides first by their charge state 
and then by hydrophilicity. Based on this, Young et al. proposed a high-throughput 
approach using a gradient of decreasing organic solvent and decreasing pH on a 
commercial WCX-HILIC resin to separate and analyze by a “Middle Down” approach 
differentially modified histones domains (77) (See also paragraph 2.5). 
In summary, an inconvenience of the “Top Down” and “Middle Down” approach is 
the need for specialized software to summarize the complex combinatorial networks 
existing among hPTMs. The main problems concern the complexity of the MS/MS spectra 
generated, either from intact histones or from large peptides, and the increased incidence of 
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internal peptide sequence fragments that further complicate the sequence annotation and 
consequently the PTM site-specific attribution in the MS/MS spectra (78-80). 
Improvements in computational approaches should enable more detailed comprehension 
and visualization of the inter-reliant relationships between unique modified forms. 
 
Figure 9. Schematic representation of “peptide-centric” versus “protein-centric” MS 
analytical strategies. 
 
 
 
2.2.3 Data analysis and bioinformatics tools for hPTM analysis by MS 
Efficient analysis of very large amounts of raw data is crucial in MS-based 
proteomics. Several MS/MS database search programs have been developed to interpret 
the large amount of data generated by modern mass spectrometers and their basic 
functionality is illustrated in Figure 10. Typically protein identification algorithms work as 
follows: they take the fragment ion spectrum of a peptide as input and score it against 
theoretical fragmentation patterns constructed for peptides from the searched database. The 
pool of candidate peptides is restricted based on user-specified criteria such as mass 
tolerance, proteolytic enzyme constraint and types of post-translational modification 
allowed. The output from the program is a list of fragment ions spectra matched to peptide 
sequences, ranked according to the search score. The search score measures the degree of 
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similarity between the experimental spectrum and the theoretical spectrum, and therefore 
serves as the primary discriminating parameter for separating correct from incorrect 
identifications. 
 
Figure 10. Peptide identification by MS/MS database searching. Adapted from  Nesvizhskii 
A.I. et al. Nature Methods 2007. 
 
                   
 
Of particular relevance for the analysis of the modifications that occur on histones are tools 
that enable identification of several different PTMs, often co-existing on the same peptide. 
Identification of PTM-bearing peptides in sequence databases, however, is more 
challenging than that of unmodified forms because the database search engine needs to 
take into account the diversity of modified forms that might exist. There are at present a 
number of computational methods available for the automated annotation of PTMs in 
peptides (Table 1). These methods analyze the MS and MS/MS data, taking into account 
the delta-mass values, and sometimes also neutral losses and other diagnostic ions for the 
PTM of interest (81). 
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Table 1. Software and search algorithms used to study hPTMs 
                           
The computational methods used to identify PTMs fall into two categories (31). In the first, 
the user selects a set of PTMs of interest prior to employ the bioinformatics tool for peptide 
and protein identification. This option is applied during the sequence database search, 
when PTMs are assigned to the relevant amino acids of a candidate peptide sequence. To 
limit the complexity required to search a very large set of possible modified forms, a 
restriction is usually imposed on the number of modifications that may be included in this 
search. 
In the second approach, which is unbiased, PTMs are identified through a “blind” 
database search. In the initial step, a basic database search is performed, excluding the 
specification of PTMs of interest, but often specifying recurring/standard modifications 
such as oxidized Methionine, for example. The specification of this relatively common 
modification avoids false-positive PTM assignments later on. Once a set of peptides is 
identified in an MS/MS-based proteomics experiment the idea is that, since the PTM leads 
to a mass increment or deficit of the modified peptide relative to the form without the 
modification present, all unassigned MS/MS spectra can be searched to find those which 
might match a post-translationally modified form. The software therefore inspects 
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unassigned spectra, using information based on a list of known modifications such as delta-
mass values and lists of predicted and observed peptide masses. 
Computational methods that search for post-translational modifications are however 
associated with higher rates of false-positive identifications. The combinatorial issues 
associated with assigning the masses of included modifications can dramatically increase 
the number of peptide and protein candidates in the output. In this regard though, 
technological improvements that enable higher mass accuracies when generating the MS 
and/or MS/MS spectra have helped to address this issue (82). 
High-resolution mass analyzers can resolve and identify peptides bearing 
modifications with similar delta-mass values as well as multiply charged ions in MS/MS 
spectra. Recent data analysis software therefore considers product ions with multiple 
charges either before or during database searching.  
There are some constraints currently beyond the reach of current algorithms. The 
first is that some modifications may arise from in vitro artefacts rather than in vivo 
enzymatic activity. A well known example is the di-glycine (GG) tag which occurs on 
Lysine, and is used to determine ubiquitination sites: the elemental composition of this tag 
is identical to that of iodoacetamine, commonly used for the alkylation of Cysteines in 
standard shotgun MS proteomics workflows (83). 
Another issue is that most of the available methods are sub-optimal for the analysis 
of MS/MS spectra deriving from long peptide sequences and intact proteins, which may 
result from a “Top Down” or “Middle Down” proteomics approach. As described in the 
recent review by Sidoli et al. (31), the complexity of these spectra require more specialised 
search algorithms, which can efficiently determine monoisoptic peaks, recognize ion 
charge states and deconvolute multiply-charged ion signals into singly-charged ion mass 
values. Currently, only a few software packages are available for this purpose.
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2.3 Quantitation strategies in MS-based proteomics  
In the last few years, following the spread of mass spectrometry-based techniques, 
it became evident that qualitative identification of proteins is not sufficient for comparative 
analysis, which often require quantitative data. The direct comparison of the amount of a 
given protein across different samples is not often accurate because the intensity of MS and 
MS/MS peaks is poorly reproducible between different LC-MS runs. This is due to the 
variation in experimental conditions and the intrinsic variability of the selection of the 
precursor peptides in data dependent acquisition (DDA). Regarding the first factor, 
minimal variations in the LC system (e.g., buffer composition) or in sample preparation 
(e.g., salt or detergent content) can influence the retention time of the peptides and also the 
intensity and quality of the spectra. Minimal variations of the chromatographic run can 
affect the choice of the precursor ion to be fragmented, thus causing the acquisition of a 
MS/MS spectrum in one LC-MS run, but not in another. This phenomenon, called 
“undersampling”, limits the possibility to profile a sample completely and principally 
affects low abundance peptides in complex mixtures.  
Various strategies have been developed in MS-based proteomics for accurate 
protein quantitation, from single proteins up to global proteome profiling. These 
quantification strategies can be broadly divided in two groups. Label-free (LF) strategies 
use no labels, thus they can be used to compare the amount of proteins in different LC-MS 
runs without requiring particular sample handlings. Conversely, strategies based on isotope 
labeling require a specific preparation of the sample prior to LC-MS analysis. The rationale 
behind stable isotope labeling is to create a mass shift that distinguishes peptides deriving 
from different samples within a single MS analysis, thus avoiding run-to-run variations. 
Generally, a labeled and an unlabeled sample are mixed to obtain a snapshot of 
concentration of proteins associated with different biological conditions. The signals 
deriving from the two samples can be distinguished due to a known mass shift between 
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labeled and unlabeled peptides. The ratios of the intensity of heavy and light signals allow 
the accurate quantification of the relative amounts of peptides and proteins originally 
present in the two samples. The isotope can be introduced in the peptides at different 
stages, depending on the labeling approach. It is possible distinguish two main strategies: 
metabolic labeling and chemical labeling (Figure 11). 
 
Figure 11. Metabolic and chemical labeling methods. Adapted from Ong S.E. and Mann M. 
MCP 2002. 
 
 
                     
 
In the metabolic labeling, the isotope is added to growing cells as a metabolic precursor, to 
be incorporated uniformly in the proteome during protein biosynthesis. Major advantages 
of metabolic labeling techniques are that they can be applied to in vivo studies and they are 
compatible with complex purification procedures, since the samples can be mixed at the 
beginning of the workflow (even before the cell lysis) and handled together, thus 
minimizing the introduction of processing errors. Conversely, a clear drawback of these 
techniques is that it can be easily applied only to cultured cells. 
 Peptides can be chemically modified with an isotope labeled molecule that 
covalently binds the amino acids side chains or the peptide terminus. The labeling can be 
performed either before or after the proteolysis. The most common methods are isotope 
34 
 
coded affinity tagging (ICAT) (84) and isobaric tags for relative and absolute quantitation 
(iTRAQ) (85). In ICAT, two samples to be compared are labeled with Cysteine-specific 
reagents containing an affinity biotin tag for purification and a differentially isotope-
labeled chain displaying a known mass difference. Heavy- and light-labeled proteins are 
mixed and digested. Then, the tagged peptides are purified and analyzed by LC-MS. In 
iTRAQ technique, a reagent that reacts with the N-terminus and Lysine side-chains of 
peptides is used. Advantage of iTRAQ is represented by possibility of multiplexing, using 
up to eight different tags. This is of particular relevance to biological experiments in which 
multiple conditions or multiple time-points are being evaluated such as signalling 
networks. Overall, the quantification based on chemical derivatization can be applied to 
different types of sample (such as ex-vivo tissue and clinical biopsies) and is not limited to 
cultured cells, as metabolic labeling is. However, discrepancies in sample processing 
discrepancies can lead to the introduction of errors with these methods and side reactions 
can produce unwanted products. Moreover, since chemical labeling is often sequence-
dependent, a complete incorporation of the isotope can be difficult to achieve, with 
consequent risk of biased quantification. One example of metabolic labeling strategy is 
represented by SILAC (stable isotope labeling with amino acids in cell culture, see next 
paragraph).  
2.3.1 Stable isotope labeling with amino acids in cell culture (SILAC) 
SILAC is simple, powerful and accurate procedure that can be used as a 
quantitative proteomic approach in any cell culture system (86). Since mammalian cells 
cannot synthesize a number of amino acid, therefore these “essential” amino acids must be 
supplied in cell culture medium as free amino acids for the medium to support cell growth. 
Isotopically labeled analogs of these amino acids, called “heavy” form, can be synthesized 
and are available commercially. Isotopes are variants of atoms of a particular chemical 
element, which have different numbers of neutrons. The number of protons and neutrons in 
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the nucleus, known as the mass number, is not the same for two isotopes of any element. 
For example, carbon-12, carbon-13 and carbon-14 are three isotopes of the element carbon 
with mass numbers 12, 13 and 14 respectively. If the “heavy” isotope of an amino acid is 
supplied instead of the natural (or “light” form) amino acid, it will be incorporated into 
each newly synthesized protein chain. After a certain number of cell doubling, this 
particular amino acid will be replaced by its isotopically labeled analog. Hence, the SILAC 
strategy requires that two populations of cells are grown in two separate medium 
formulations, the “light” medium containing the amino acid with the natural isotope 
abundance and the “heavy” medium containing non-radioactive stable isotope chose 
(Figure 12). When light and heavy cell populations are mixed, they remain distinguishable 
by MS, and protein abundances are determined from the relative MS signal intensities (86).  
 
Figure 12. Overview of standard SILAC experiment. The SILAC experiment consists in 
two distinct phases: (a) an adaptation and (b) experiment phase. (a) Cell are grown in 
“light” and “heavy” media until fully incorporation (red star) (b) The two cell populations 
are mixed, protein are purified, digested and analyzed by MS. Adapted from Ong SE, Mann M. 
MCP 2002. 
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The possibility offered by this strategy to combine two cell populations from distinct 
media at a very early stage of the MS-proteomics workflow, significantly reduces the 
effects of experimental variations in sample preparation, thus leading to very accurate 
quantitation, which only takes into account changes caused by the different functional 
states.  
The first SILAC experiments used 2H3-Leu; the current protocols instead use 
labeled Arginine and Lysine (e.g. 13C6-Lysine and 13C6-Arginine), which offer the 
advantage to produce, upon digestion with Trypsin, most peptides containing a labeled 
amino acid. Typically, a cell line is cultured for at least 5 rounds of divisions in labeling 
medium, to achieve extensive proteins labeling (>95%): this procedure does not interfere 
with protein activity. Labeled and unlabeled cell lines or extracts are then mixed and 
analyzed together by LC-MS. SILAC has become a very popular technique and has been 
applied to the study of protein interactions (87, 88) and signaling networks (89, 90) but 
also in the investigation of post-translational modifications.  
2.4 Quantitative MS-based approaches in epigenetic research 
Different quantification strategies have been employed to the measurement of 
histone modification, variants and turnover. Chemical derivatization as a means to modify 
cleavable residues has been widely applied in epigenetic studies for their technical 
advantages, previously described (63, 64). In addition, the alkylation of Lysines with the 
deuterated acetic anhydride can also be used to quantitatively estimate the acetylation 
status of histones. For instance, distinct acetylated forms of H4 in Drosophila 
melanogaster and their developmental changes have been profiled using D6-acetic 
anhydride prior digestion and MS-analysis (61). Similarly, propionylation of histones was 
used to observe the effect of G9a/Glp1 methyltransferase knockdown on global histone 
modifications (39). 
37 
 
Other chemical derivatization strategies, such as TMT (tandem mass tag) and 
iTRAQ, have only been employed on chromatin for protein-level profiling, with focus on 
PTM level changes (91-93). 
In vivo metabolic labeling with isotope-encoded amino acids has emerged as the 
most powerful approach to accurately quantify changes of histones and their PTMs. In the 
last years, SILAC has gained wide popularity in proteomics and, more recently, also in 
chromatin studies (35, 94-96). SILAC is preferentially used to profile protein levels; 
however it has also been successfully applied to identify and quantify hPTMs, and in 
particular to profile modification dynamics during the cell cycle: Bonenfant et al showed 
increasing phosphorylation on histone H3 and H4 and decreasing methylation of 
H3K27/K36 during mitosis (97) while Pesavento et al. proved that H4K20 methylation 
degree was tightly linked to cell cycle progression (99). A SILAC-indipendent approach is 
used by Scharf et al. to demonstrate that H4K20 mono-methyaltion facilitates chromatin 
maturation ((98, 99). Using a SILAC MS-based experiment, Jung et al. showed that 
Polycomb repressive complex Suz-12 promotes the establishment of H3K27 di/tri-
methylation in mouse embryonic stem cells, with a functional interplay between H3K27 
tri-methylation and H3K27 acetylation, functioning as molecular switch in this system 
(100). Our group also used a modified version of the SILAC approach to determine breast 
cancer-specific histone PTM signatures. In this study, we focused on human breast cancer 
and comprehensively analyzed PTMs on histone H3 and H4 from four cancer cell lines 
(MCF7, MDA-MB231, MDA-MB453 and T-47D), in comparison with normal epithelial 
breast cells (MCF10). The SILAC-MS based approach enabled to quantitatively track the 
modification changes in cancer cells, as compared to their normal counterpart. With the 
accuracy of this strategy, it was possible to identify PTMs specifically associated to 
distinct type of breast cancer cell line with different properties (aggressiveness/prognosis). 
Among them some were already known as modifications linked to cancer, such as a 
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decrease of H4K20 tri-methylation, whereas some emerged as novel markers of breast 
cancer, such as decreased levels of H3K9 tri-methylation (101). 
SILAC labeling in a pulse experiments were used to probe the turnover of both 
hPTMs and histone variants: Zee et al. showed that H2A.Z has higher turnover rates than 
canonical H2A variants and, more generally, that acetylated histone peptides appear to 
turn-over much faster than methylated ones (102). 
Heavy-methyl SILAC (hmSILAC) is a variation of SILAC used for high 
confidence identification of protein methylation at Lysines and Arginines. In heavy methyl 
SILAC labeling, 13CD3-methionine is added to Methionine-depleted media; upon uptake in 
the cell, the “heavy” Methionine is converted into S-adenosyl Methionine (SAM), the sole 
donor of methyl groups in enzymatic methylation reaction. As such, histone and all non-
histonic proteins that contain methylations are enzymatically heavy-methyl labeled. Such 
isotopically methylated peptides are then identified with high confidence in MS, based on 
the presence of the specific ‘light and heavy peak pair’, markers of methylation, and 
subsequently quantified. Ong et al. first used this strategy to identify unambiguously 
methylated sites in vivo on both histones and non-histonic proteins (103). Afterwards, 
hmSILAC was applied to study the dynamic turnover at H3K9 tri-methylation in 
pericentric chromatin (103, 104). More recently, the same approach was applied to profile 
the dynamic turnover of histone Lysine methylation, revealing that mono-, di-, and tri-
methylated residues generally have progressively slower rates of formation. Furthermore, 
methylations associated with active genes were found to have faster rates than 
methylations associated with silent genes (105). 
A combination of both standard and heavy-methyl SILAC in pulse-chase 
experiments, carried out on synchronized cells, enabled Sweet et al. to track the 
progression of H3K79 methylations throughout the cell cycle (106). In addition, it was 
observed that H3K79 mono-methylations from newly-synthesized histone H3 proteins 
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have the same turnover rates as those in pre-existing histones, with no differences among 
the three histone H3 variants (106). 
Label-free or ion intensity-based quantitation strategies have been applied in a few 
studies to profile differently modified, but isobaric histone isoforms, which have a special 
feature to present identical molecular weight/mass (isobars) but different PTMs 
configurations, so they are undistinguishable in full MS and can be hardly separated by 
standard LC. Since in MS/MS such isobaric species are distinguishable based on the 
positional selectivity of ion fragmentation, a relative quantitation is possible in a label-free 
MS/MS-based manner, using the relative ratios of their fragment ions. “Top Down” intact 
histone protein analyses were successfully used to quantify different modified forms of 
H3.2 and H4, in a label-free approach (107, 108) (See also paragraph 2.5). 
Lastly, synthetic, isotopically labeled peptides can be used as internal standards for 
both relative and absolute quantitation of histones and their PTMs, in “spike in” assays. 
Briefly, isotope-encoded peptides are synthesized with the same sequence of the modified 
histone peptide of interest, derived from the endoproteinase digestion used in the study. 
Relative quantitation is obtained when a known concentration of the standard peptide is 
“spiked into” each histone sample from the panel under investigation, and the intensity of 
the each native modified peptide is compared with that of the standard. With the same 
approach the absolute quantitation of modified peptides can be also achieved, when a 
calibration curve of the ion intensity versus the peptide standard, injected at distinct 
concentrations, is calculated. Typically, this approach is combined with single or multiple 
reaction monitoring MS (SRM/MRM), which allows a very sensitive detection of even 
sub-stoichiometric modifications. This technique benefits from the triple quadropole 
(QQQ) instrumentation. Briefly, targeted peptides are selected in the first mass analyzer 
(Q1), fragmented by CID (in Q2) and one or several of the fragment ions uniquely derived 
from the targeted peptide are measured by the third analyzer (Q3). In this way, each 
peptide is characterized by a specific “transition” which links both the precursor and 
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fragment ions, observed in both analyzers. The identity of each peptide can be inferred 
from the “transition” and the relative abundance can be estimated from the transition 
intensity relative to that of the standard (109). Darwanto and coworkers have successfully 
employed SRM upon spike in of isotopically encoded histone peptides in U937 lymphoma 
cells, expressing a mutated form of the hDot1a methyltransferase. They profiled changes in 
a set of hPTMs and observing that in these conditions the observed decrease of H3K79 
methylation parallels a corresponding increase in H2B K120 ubiquitination (110). 
2.5 Mass Spectrometry analysis of histone variants and their modifications  
In addition to post-translational modiﬁcations, histone variants contribute to the 
epigenetic regulation of gene expression (111). Histone variants typically accumulate at 
specific genomic regions and show unique modification patterns, affecting a variety of 
chromatin-related processes. Some interpretative models propose that they represent an 
“extra layer” of the histone code (112), providing additional mechanisms to modulate 
chromatin structure. However, at least for the majority of variants, the processes by which 
specific variants accumulate at certain regions and are transmitted throughout the cell cycle 
remain unclear. Except for H4, all core histones and linker histones H1 have a number of 
variant counterparts (Figure 13), often differing in a few amino acids, which hampers their 
analysis via conventional approaches, such as antibody-based assays. 
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Figure 13. Comparison between histone variant sequences. Histone variants contain a 
highly conserved histone fold domain and differ mainly in their C and N-terminal 
sequences. Boxes represent the histone fold domain and orange lines represent site-specific 
sequence variations. Histones that are in different shades of the same color are from the 
same histone family but have large differences in sequence. Adapted from Arnaudo A.M et al. 
Crit Rev Biochem Mol Biol. 2011 (113). 
 
                                        
 
Mammalian histone H3 has three major variants (H3.1, H3.2 and H3.3), in addition to a 
testis-specific variant (H3t) and a centromeric variant (CENP-A). The major variants are 
very similar in sequence composition. Histone H3.1 differs from H3.2 by a change in 
Cysteine 96 to Serine, while H3.3 differs from H3.1 by only 5 residues. However, they 
display differences in their expression, enrichment at specific chromatin domains, and in 
their post-translational modification signatures. Studies of the PTM patterns of H3 variants 
have been performed, profiting from all MS approaches described: “Bottom Up”, “Top 
Down” and “Middle Down”. “Bottom Up” analysis of mammalian, Arabidopsis thaliana, 
and Drosophila melanogaster H3 variants revealed that H3.3 is enriched in modifications 
associated with transcriptional activity (114-116). “Top Down” analysis of H3 variants 
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from rat brains showed comparable results using this complementary approach (117). 
Affinity purification of epitope-tagged H3.1 and H3.3 revealed a distinct set of 
modifications occurring on these two H3 variants before and after their assembly on 
chromatin, suggesting that pre-assembly modifications determine their final fate, as well as 
their PTM patterns on chromatin (68). A combinatorial view of modifications on H3.1 and 
H3.3 from asynchronous or colchicine-treated HeLa was achieved by “Top Down” 
revealing that, in asynchronous cells, only 5% of K4 was mono-methylated and about 50% 
of K9 was di-methylated in the H3.1 pool. In addition, more than 90% of the H3.1 pool 
was observed to be acetylated: K14 and K23 represent the major sites of acetylation. Upon 
colchicine treatment however the unmodified, mono- and di- phosphorylated S10 and S28 
are detected in a 2:3:1 ratio, in addition to the K9 methylation and acetylations described. 
The absence of the K4 methylation in the colchicine-treated samples was probably due to 
the relatively small pool of molecules containing this modification (73). “Middle Down” 
analysis of H3 variants in a panel of rat tissues showed distinct patterns of H3.2 and H3.3 
levels and modification status between various tissues (118). “Middle Down” was also 
successfully applied to the identification of more than 200 modifications in H3.2 and 70 
modifications in H4 from human samples, including several that were not previously 
reported (77, 108). 
Canonical human histone H2A is encoded by sixteen genes that cluster on the 
genome. Kelleher and co-workers identified and characterized twelve unique sequences by 
using intact mass and fragmentation spectra (71). The modifications on the canonical H2A 
are incompletely characterized: only phosphorylation of S1 and acetylation on the N-
terminal K5 are reproducibly reported (119), as well as mono-ubiquitination at K119, 
involved in gene silencing and mediated by Polycomb proteins (120).  The non-canonical 
H2A variants include H2A.X, H2A.Bbd, H2A.Z and macro-H2A. H2A.X phosphorylated 
at S139 is the so-called γ-H2A.X, which localizes to sites of DNA double strand breaks 
(DSB) in response to DNA damage and thus represents a mark of the DNA damage 
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response (DDR). Acetylation and ubiquitination of H2A.X were also shown to be involved 
in this process: acetylation of K5 is a prerequisite for the poly-ubiquitination and the 
subsequent release of H2A.X from the DNA damage sites (121). H2A.Z is present at 
promoters where it is believed to maintain active chromatin in regions adjacent to silent 
ones. However, potential roles in gene silencing have also been proposed (122). 
Acetylation of K4 and K7 of this variant were identified by a “Middle Down” approach in 
Jurkat cells (119). Macro-H2A, the largest H2A variant, is generally enriched at 
transcriptionally silent regions. MS characterization of macro-H2A identified K115 
ubiquitination and S137 phosphorylation. The former is implicated in X-inactivation 
whereas the latter is enriched in mitosis (123, 124). In addition, K17 mono-methylation, 
K122 di-methylation and Y128 phosphorylation are identified (123).  
A combination of CID and ECD MS fragmentation at protein and peptide levels led 
to the characterization of several H2B variants and associated PTMs (119, 125): 
acetylation on K5, K12, K15 and K20, and ubiquitination on K120. These PTMs were 
confirmed by peptide mass fingerprinting (PMT), performed on bovine H2B, which 
revealed also K43 mono-methylation and K85 acetylation (126). “Bottom Up” approaches 
have also served to characterize modifications specific for the testis-specific variants of 
H2B (TH2B) (127). In addition, “Top Down” analysis using ECD fragmentation of the two 
major H2B variants of Tetrahymena thermophila led to the characterization of their 
primary sequences and modification patterns (128). Recently, mono-methylation and di-
methylation at the N-terminal Proline of Drosophila melanogaster H2B have been 
identified using a combination of different strategies for sample preparation prior to MS 
analysis including D6-acetic anhydride derivatization followed by Trypsin digestion and 
Asp-N digestion. The abundance of this Proline methylation seems be dependent of the 
developmental stage and is regulated by the enzyme dART8. The authors also observed 
predominant acetylation of H2B at K11 and K17 (129).  
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Histone H1 is commonly referred to as the linker histone. A single copy of this 
histone is proposed to bind near the entry/exit site of DNA on the nucleosome (the so 
called dyad), stabilizing the 30nm fiber and thus regulating higher order chromatin 
structure and stability (Figure 14) (130). Sequence divergence between histone H1 
isoforms occurs mainly in the N- and C-terminal regions of the proteins, generating as 
many as eleven mammalian isoforms. 
 
Figure 14. Binding of linker histone H1 to the nucleosomal string induces chromatin 
compaction. Chromatin ﬁber compaction induced by binding of linker histone H1. The left 
ﬁber represents an open conformation with straight linker DNA in the absence of linker 
histones, in which DNA access is facilitated for other proteins. The binding of linker 
histone H1 changes the local nucleosome geometry. This induces a transition to more 
compacted ﬁber  conformations  in  which  the  DNA  is  less  accessible. Adapted from 
Wachsmuth M. et al. Biochimica et Biophysica Acta 2008. 
 
                            
 
Mass spectrometry analysis, in combination with other experimental techniques, led to the 
identification of a number of PTMs specifically enriched on distinct linker histones, such 
as methylation, phosphorylation, acetylation, ubiquitination, formylation and ADP 
ribosylation (131-135). RP-HPLC of the different H1 variants, followed by chemical 
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derivatization of the protein with propionic anhydride and subsequent LC-MS/MS analysis 
revealed a K26 methylation and S27 phosphorylation on histone H1.4. Methylation on K26 
appears to recruit heterochromatin protein1 (HP1), whereas phosphorylation at S27 
appears to inhibit HP1 binding, so that these two adjacent PTMs are believed to function as 
a molecular switch for the modulation of gene expression silencing (133, 136). Moreover, 
the “Top Down” analysis of intact H1.2 and H1.4 molecules purified at distinct cell cycle 
stages suggested that S173 on H1.2 and S187 on H1.4 are phosphorylated only during 
interphase. Interphase phosphorylated H1.2 and H1.4 are associated with active rDNA and 
facilitate RNA pol I transcription. Finally, phosphorylation of H1 affects its chromatin 
dissociation and, in turn, chromatin accessibility to factors that regulate transcription and 
replication (137). 
2.6 Interaction proteomics to study chromatin architecture 
An improved knowledge of chromatin composition can contribute to a more 
comprehensive view of its higher-order structure and function. Until now, no purification 
method has emerged as a “gold standard” for chromatin purification and characterization 
due to the difficulty in enriching chromatin samples from specific functional regions in a 
quantity and purity sufficient for subsequent analysis. However, thanks to recent 
improvements in sensitivity and accuracy of MS-based quantitative proteomics a number 
of studies have demonstrated the high potential of this technology to characterize the 
chromatin proteome, with a specific focus on the histone code readers associated with 
specific functional states of chromatin (Figure 15). 
The first attempt to characterize proteins associated with chromatin was the 
analysis of changes in protein levels in response to the overexpression of the oncoprotein 
MYC. This was done using differential detergent/salt extraction and chemical isotopic 
labeling by ICAT, in combination with multi-dimensional chromatography and mass 
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spectrometry (138). Subsequently, when ad hoc biochemical protocols were established for 
the purification of distinct chromosomes, MS proved to be a successful tool to characterize 
their protein composition: mitotic chromosomes were purified at different stages of the cell 
cycle (mitosis, metaphase and interphase) and co-associated non-histone proteins were 
characterized by MS (139-144). More recently, a multiclassiﬁer combinatorial proteomics 
(MCCP) approach was developed where SILAC quantitative proteomics is integrated with 
a bioinformatics analysis pipeline. A statistical approach is applied to confirm which 
known and uncharacterized proteins are chromosomal, to obtain a more comprehensive 
collection of proteins associated at high confidence with mitotic chromosomes (145).  
One elegant methodology to study the proteomic composition of telomeric regions 
was developed by the Kingston group using the PICh (proteomics of isolated chromatin) 
approach. In this approach, enrichment of cross-linked telomeric chromatin was achieved 
using DNA probes complementary to the telomeres, rich in repetitive sequences. The co-
enriched proteins were characterized by MS and new telomere-associated proteins were 
observed (146). Yet, a drawback of PICh was the limited applicability to regions rich in 
repetitive DNA sequences. 
All these methods provide a useful contribution to the knowledge of protein 
composition in large chromosomal regions or even intact chromosomes, but they are 
inadequate for obtaining information on chromatin locus-specific composition. 
Recently, a number of interactomics assays combining affinity-interaction mapping 
with SILAC-quantitative MS read-out have been developed for the comprehensive 
characterization of hPTM “readers”. Vermeulen et al. used pull-down assays with peptides 
that differ by a single post-translational modification to identify specific binders, either as 
individual interactors or as multiprotein complexes. Whit such approach, they discovered 
that TFIID binds H3K4 tri-methylation and recruits the entire transcription initiation 
complex, thereby providing a functional link between this modification and activation of 
transcription (88). The approach was extended further to screen all major tri-methylation 
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marks on histones and, in combination with ChIP-Seq and BAC-GFP pull-downs, to define 
the comprehensive Lysine trimethyl-interactome (147). As an additional elaboration of the 
strategy, a SNAP (SILAC Nucleosome Affinity Purification) approach was established 
where recombinant nucleosomes bearing combinations of hPTMs and methylated DNA 
were used as baits to provide a “modification binding profile” for proteins regulated by the 
contribution of both DNA and histone methylations (148). Similarly, a SILAC-based 
affinity purification assay was carried out with recombinant, uniformly modified chromatin 
templates (149). In addition, the CLASPI (Cross-Linking Assisted and SILAC-based 
Protein Identification) approach has been described, which combines SILAC with 
chemical proteomics using photo-crosslinking-based histone peptide probes, to detect weak 
but specific interactions that may escape standard pull-down approaches (150). Finally, 
peptide arrays and MS have been employed to systematically uncover methyl-Lysine and 
chromatin-binding module interactors, as well as to identify novel H3K23 mono-
methylation marks, able to facilitate the recruitment of HP1β to the heterochromatin (151). 
These in vitro studies are very powerful tools for screening the soluble binders of 
hPTMs, but fall short in extracting information on the relative PTM stoichiometry, 
combinations as well as their synergies with histone variants and chromatin modifiers, 
under physiological conditions. Hence, the locus-specific determination of hPTM patterns 
and their interactions with protein complexes remains a very attractive, partially 
unachieved goal. 
A SILAC-based quantitative proteomics approach was employed to generate a 
differential profile of proteins associated with specific euchromatin and heterochromatin 
regions. This approach exploited the different accessibility of these regions to MNase, as a 
consequence of their differential nucleosome packaging. Upon limited MNase treatment, 
the two fractions of chromatin were separated by centrifugation, based on the differential 
density of the nucleosomal stretches, and SILAC was used to discriminate the proteins 
associated with these two functional chromatin regions (152). Another approach developed 
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for detection and characterization of proteins associated with specific chromatin domains 
was mChIP (153), where chromatin is isolated, sheared and then analysed by MS. mChIP 
was successfully applied to study the interactomes of H2A (Hta2p) and its variant Htz1p in 
Saccharomyces cerevisiae.  However, this study did not provide quantitative information 
on binding proteins.  
In this respect, global investigations of synergies between histone PTMs, variants, 
and chromatin-associated proteins in a locus-specific manner still remain a very attractive 
unachieved goal. 
 
Figure 15. Different biochemical approaches for the proteomic characterization of 
chromatin composition and architecture. Some strategies address the chromosome as a 
whole (A), whereas others are focused on the characterization of specific chromatin 
regions: telomeres (B); regions enriched with distinct hPTMs (C, D), or certain histone 
variants (E).   
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3. AIM OF THE PROJECT 
Chromatin architecture and its functional state are regulated by different associated 
proteins, post-translational modification of histone (hPTMs) and DNA methylation, which 
act in a concerted manner to create a “chromatin landscape”, with regulatory effect on gene 
expression. While extensive ChIP-Seq data are already available for all virtually known 
hPTM, and for a large set of chromatin binders, the investigation of the proteomic 
composition of chromatin started more recently and is still an ongoing effort. Recent 
studies focusing on protein components of chromatin were mainly focused on the 
characterization of histone code readers. These in vitro studies are very powerful tools for 
screening the soluble binders of hPTMs, but information on the relative PTM 
stoichiometry, combinations as well as their synergies with histone variants and chromatin 
modifiers remain still largely incomplete. 
With these restraints in mind, and since I joined a group studying chromatin-
mediated regulation of gene expression by quantitative proteomics, I developed a PhD 
project focused on the design and optimization of a novel biochemical and analytical 
method for the large-scale characterization of hPTM patterns and non-histonic proteins co-
associated with specific functional regions of chromatin.  
To this purpose, I combined chromatin immunoprecipitation (ChIP) and Mass 
Spectrometry (MS) analysis in order to establish an approach that could profit from the 
strengths of both methods, overcoming their respective limitations. ChIP using antibodies 
against specific modifications as “bait” were carried out to enrich specific functional 
chromatin domains at yield and purity sufficient for subsequent MS analysis. MS was then 
employed to characterize the co-associated hPTMs and to annotate all the proteins 
specifically interacting within the same chromatin domains. In particular native ChIP (N-
ChIP), using unfixed chromatin selectively digested by micrococcal nuclease (MNase) was 
used in combination with MS to dissect PTM interactions, whereas cross-linking ChIP (X-
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ChIP) in combination with SILAC quantitative proteomics was set to screen the specific 
interactions at the selected regions. It has already been widely demonstrated that in fact 
SILAC-based interactomics is particularly efficient in discriminating with high confidence 
specifically binders from backgrounds (see paragraph 2.5).  
Since the method is completely novel, it was essential to demonstrate its robustness 
and reliability, which involved part of my work during these years. As proof of principle I 
used this approach to characterize silent and active chromatin regions, marked by 
H3K9me3 and H3K4me3, respectively. The accordance of the obtained results on hPTMs 
analysis and co-associated proteins with previous studies proved the robustness of our 
strategy. Basing on these achievements, the future perspective is to apply this strategy to 
extend the analysis on new modifications and variants enriched at regulatory regions, in a 
more biological and relevant model system (see paragraph 7). 
51 
 
4. MATERIALS and METHODS  
4.1 General biochemistry buffers  
(for buffers used in specific protocols, see the dedicated corresponding paragraphs) 
1. Phosphate-Buffered Saline (PBS), pH 7.4: 
            137 mM NaCl 
            2.7 mM KCl 
            8.1 mM Na2HPO4(7H2O)  
 1.76 mM KH2PO4 
2.  Tris-Buffered Saline (TBS): 
           150 mM NaCl 
           2.7 mM KCl 
           25 mM Trizma HCl 
3. Urea lysis buffer: 
 20 mM Hepes, pH 8.0 
 9 M Urea 
4. Running gel mix  (1 gel at 17.5%): 
Acrilamide/Bis-acrylamide stock solution - 37.5:1 ratio (3.48 mL) 
Tris-HCl,  pH 8.8 (1.5 mL) 
ddH2O (0.96 mL) 
SDS 20% (30 µL) 
APS 20% (30 µL) 
TEMED (3 µL) 
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5. Stacking gel mix (2 gel): 
Acrilamide/Bis-acrylamide stock solution - 37.5:1 ratio (0.52 mL) 
Tris-HCl, pH 6.8 (1.25 mL) 
ddH2O (3.10 mL) 
SDS 20% (25 µL) 
APS 20% (25 µL) 
TEMED (5 µL) 
6. LDS sample loading buffer (1X): 
10% Glycerol 
1% Lithium dodecyl sulfate (LDS) 
1% Ficoll-400 
0.2 M Triethanolamine-Cl pH 7.6 
0.00625% Coomassie G250 
0.5 mM EDTA disodium 
7. SDS-PAGE running buffer: 
 25 mM Tris base 
 192 mM Glycine 
  2% SDS 
8. Fixing gel solution: 
50% Methanol 
10% Acetic acid  
9. Staining gel solution: 
20% Methanol 
20% Stainer A (Colloidal Blue Stain Invitrogen Kit) 
5% Stainer B (Colloidal Blue Stain Invitrogen Kit) 
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10. Western transfer buffer: 
 25 mM Tris base 
 192 mM Glycine 
 20% Methanol 
11. Stripping buffer: 
62.5 mM Tris-HCl, pH 7.6 
 2% SDS 
100 mM β-Mercaptoethanol 
12. Tris-borate-EDTA (TBE): 
89.2 mM Tris base, pH 7.6 
88.95 mM Boric acid 
2 mM EDTA, pH 8.0 
4.2 Cell Culture and SILAC labeling 
HeLaS3 cells were grown in Dulbecco's modified Eagle's medium (DMEM, 
Invitrogen) supplemented with 10 % Fetal Bovine Serum (FBS, Invitrogen 10270-106), 
1% Glutamine, 1% Pen/Strep and 10 mM HEPES pH 7.5. For metabolic labeling, HeLa S3 
cells were grown in ‘‘Heavy’’ and ‘‘Light’’ SILAC media prepared adding to the SILAC 
DMEM (M-Medical FA30E15086), depleted of Lysine and Arginine, 10% dialyzed FBS 
(Invitrogen, 26400-044), 1% Glutamine, 1% Pen/Strep, 10 mM HEPES pH 7.5 and either 
the light isotope-coded amino acids 12C6 14N2 L-Lysine (Lys 0, Sigma L8662) and 12C6 
14N4 L-Arginine (Arg0, Sigma A6969) or their heavy isotope-counterparts: 13C6 15N2 L-
Lysine (Lys 8, Sigma 68041) and 13C6 15N4 L-Arginine (Arg10, Sigma 608033). Lys and 
Arg were added at a concentration of 73 mg/L and 42 mg/L, respectively. HeLaS3 were 
cultivated in SILAC media for 9 generations, with careful monitoring of growth rate, 
viability and overall morphology, to ensure that normal physiology is preserved.  
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NIH 3T3 mouse fibroblasts were grown in DMEM supplemented with 10 % Calf 
Serum (CS, Lonza 14-401F), 1% glutamine and 1% Pen/Strep. 
4.3 Native chromatin immunoprecipitation (N-ChIP)  
The protocol developed was modified from a previously described one (154). Two 
hundred millions HeLa S3 cells were homogenized in Lysis Buffer and nuclei were 
separated from cytoplasm, by centrifugation at 3750 rpm (4°C) for 30 minutes, putting 
cellular lysate on sucrose cushions. Nuclear pellets were washed twice with PBS, re-
suspended in Digestion Buffer and digested with micrococcal nuclease (MNase, Roche) at 
a final concentration of 0.005 U/ml, at 37 °C for 60 minutes. The reaction was stopped by 
adding 1 mM EDTA and chilling on ice. The soluble fraction of chromatin (S1), 
comprising small fragments (mono-, di-nucleosomes), was collected as the supernatant 
obtained after centrifugation of re-suspended nuclei at 10000 rpm (4 °C) for 10 minutes. 
Pellets were instead re-suspended in Dialysis Buffer and dialyzed overnight at 4 °C in a 
dialysis tube (cut off 3.5 kDa). The second soluble fraction of chromatin (S2), comprising 
large fragments (tri- to epta-nucleosomes), was as the supernatant obtained after 
centrifugation at 10000 rpm (4 °C) for 10 minutes. DNA extracted by Qiaquick columns 
(QUIAGEN) was run on 1% agarose gel to evaluate fractions of chromatin. The S1 
fraction is combined with a small aliquot of S2 fraction (1/100) in order to obtain an Input 
compose of about 95% of mono-nucleosomes. Chromatin was immunoprecipitated with 10 
µg of the following antibodies: H3K9me3, H3K4me3 and H2AX. Antibodies were 
incubated overnight with chromatin; in parallel, 100 µl of G protein-coupled magnetic 
beads (Dynabeads, Invitrogen 100.04D) were blocked in BSA 0.5% PBS for an overnight. 
Blocked beads were washed and added to chromatin and incubated for 3 h at 4°C on a 
rotating wheel. Beads were washed four times (50 mM Tris-HCl pH 7.6, 10 mM EDTA) at 
increasing salt concentration (75, 125 and 175 mM NaCl). LDS Sample Buffer (Invitrogen 
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NP0007) supplemented with 50 mM DTT was added to the beads for 5 min at 70 °C to 
elute the immunoprecipitated proteins from the beads. Proteins were resolved on 4-12% 
Bis-Tris acrylamide SDS-PAGE pre-cast gels (Invitrogen NP0335BOX) on an Invitrogen 
system and visualized on the gel using Colloidal Comassie staining Kit (Invitrogen 
LC6025). 
4.3.1 Buffers for N-ChIP: 
1. Lysis Buffer: 10% sucrose, 0.5 mM EGTA pH 8.0, 15 mM NaCl, 60 mM KCl, 15 
mM HEPES, 0.5% Triton, 0.5 mM PMSF, 1mM DTT, 5 mM NAF, 5 mM Na3VO4, 
5mM NaButyrate, 5 mg/ml Aprotinin, 5 mg/ml Pepstatin A, 5 mg/ml Leupeptin. 
2. Digestion Buffer: 0.32 M sucrose, 50 mM Tris-HCl pH 7.6, 4 mM MgCl2, 1 mM 
CaCl2, 0.1 mM PMSF.  
3. Dialysis Buffer: 10 mM Tris-HCl pH 7.6, 1 mM EDTA, 0.5 mM PMSF, 5 mM 
NAF, 5 mM Na3VO4, 5mM NaButyrate, protease inhibitors cocktail. 
4.4 Cross-linking Chromatin immunoprecipitation (X-ChIP) 
The protocol developed was a modification from a previously published one (155). 
Two hundred millions SILAC-labelled HeLa S3 cells were harvested; cell pellets were 
cross-linked in 0.75% formaldehyde PBS for 20 min at room temperature (RT) to stabilize 
protein-DNA and protein-protein interactions, with shaking on rotating wheel. 
Formaldehyde was quenched adding 125 mM Glycine for 5 min. After four washes with 
cold PBS, cells were suspended in Lysis Buffer for 10 min at 4°C. After centrifugation the 
nuclear pellets were washed once with Washing Buffer and then re-suspended in ChIP 
Incubation Buffer. Chromatin from nuclei was sonicated at 200 W for 15 min (cycles of 30 
sec “on” and 1 min “off”, in a cooled Bioruptor (Diagenode). After sonication, 1% of 
Triton-100 was added to sonicated chromatin to pellet debris. Soluble nucleosomes, 
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contained in the soluble supernatant after centrifugation at 13000 rpm (4°C) for 10 
minutes, were immunoprecipitated by adding 10 µg of the following antibodies: H3K9me3 
and H3K4me3 and H2A.X. The immunoprecipitation procedure followed the steps as for 
the N-ChIP, except for the washes, which were carried out in 20 mM Tris-HCl pH 7.6, 2 
mM EDTA, 0.1% SDS,1% Triton-100 and increasing NaCl concentration (150 and 300 
mM). To reverse the crosslinking and elute the immunoprecipitated proteins, SDS-PAGE 
sample buffer (250 mM Tri-HCl pH 8.8, 0.5M β-mercaptoethanol, 2% SDS) was added to 
the beads for 25 min at 95 °C. Proteins were resolved on 4-12% Bis-Tris acrylamide SDS-
PAGE pre-cast gradient gels Invitrogen system and visualized by Colloidal Comassie 
staining kit (Invitrogen). For DNA damage experiment the cells were treated with 
etoposide (Sigma E1383) at the concentration of 30 µM or DMSO (as control) for 1h, 2h, 
4h and 8h to induce DSBs. After 3 h washing cells with fresh medium, cells were 
harvested and treated for a X-ChIP as previously described using antibodies against 
H3K9me3 and H3K4me3.  
4.4.1 Buffers for X-ChIP: 
1. Lysis Buffer: 50 mM HEPES-KOH pH 7.5, 140 mM NaCl, 1 mM EDTA, 10% 
glycerol, 0.5% NP-40, 0.25% Triton-100, 0.5 mM PMSF, 5 mM NAF, 5 mM Na3VO4, 
5mM NaButyrate, 5 mg/ml Aprotinin, 5 mg/ml Pepstatin A, 5 mg/ml Leupeptin. 
2. Washing Buffer: 10 mM Tris-HCl pH 8, 200 mM NaCl, 1 mM EDTA, 0.5 mM 
EGTA, 0.5 mM PMSF, 5 mM NAF, 5 mM Na3VO4, 5mM NaButyrate, 5 mg/ml 
Aprotinin, 5 mg/ml Pepstatin A, 5 mg/ml Leupeptin. 
3. ChIP Incubation Buffer: 10 mM Tris-HCl pH 8, 100 mM NaCl, 1 mM EDTA, 0.5 
mM EGTA, 0.1% sodium deoxycholate, 0.5% sodium lauroylsarcoside, 0.5 mM 
PMSF, 5 mM NAF, 5 mM Na3VO4, 5mM NaButyrate, 5 mg/ml Aprotinin, 5 mg/ml 
Pepstatin A, 5 mg/ml Leupeptin. 
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4.5 In-gel digestion of histones for MS analysis  
Bands corresponding to the core histones were excised from the gel, de-stained 
with repeated washes in 50% acetonitrile (ACN) in ddH2O, alternated with dehydration 
steps in 100% ACN. Gel pieces were in gel chemically alkylated as previously described, 
by incubation with D6-acetic anhydride (Sigma 175641) 1:9 in 1M NH4HCO3 and 
CH3COONa solution as catalyzer (61). After 3h at 37 °C with high shaking in thermo 
mixer, chemically modified gel slices were washed increasing ACN % (50% and 100%). 
In-gel digestion was performed with 100 ng/µl trypsin (Promega V5113) in 50 mM 
NH4HCO3 at 37 °C overnight, in order to obtain an “in-gel”-like Arg-C digestion, which 
cleaves at the amide bond C-terminal to Arginine residues, producing peptides with an 
optimal length for MS analysis. Digested peptides were extracted, desalted and 
concentrated using a combination of reverse-phase C18/Carbon “sandwich” system and 
ion-exchange (SCX) chromatography, on hand-made nano-columns (StageTips) (156): 
digested peptides loaded on C18/C and SCX StageTips were then eluted with high organic 
solvent (80% ACN) and NH4OH, respectively. Eluted peptides were lyophilized, re-
suspended in 0.1% TFA and 0.5% acetic acid in ddH2O, pooled and subjected to LC-
MS/MS. 
4.6 In-gel digestion of immunopurified proteins 
 Processing of gel- separated proteins prior MS analysis was carried out as 
previously described, with minor modifications (66). Briefly, slices were cut from gels and 
de-stained in 50% v/v acetonitrile (ACN)/50 mM NH4HCO3. Reduction was carried out 
with 10 mM DTT in 50 mM NH4HCO3, followed by alkylation with 55 mM 
iodoacetamide in 50 mM NH4HCO3. In-gel digestion was performed with 12.5 ng/µL 
trypsin (Promega V5113) in 50mM NH4HCO3, overnight at 37 °C.  
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Digested peptide were extracted with 3%TFA, 30%ACN and finally with 100% ACN, 
lyophilized, desalted and concentrated on C18 Stage Tips (156). Samples were loaded in 
1% TFA and 5% ACN and eluted with high organic solvent (80% ACN). Eluted peptides 
were lyophilized, re-suspended in 0.1% TFA and 0.5% acetic acid in ddH2O, and 
subjected to LC-MS/MS analysis.  
4.7 Liquid Chromatography and Tandem Mass Spectrometry (LC-MS/MS) 
 Peptide mixtures were separated by nano-liquid chromatography using Agilent 
1100 Series (Agilent Technologies), coupled to a 7-Tesla LTQ-FT-ICR-Ultra mass 
spectrometer (ThermoFisher Scientific, Bremen, Germany). The nanoliter flow LC was 
operated in one column set-up with a 15 cm analytical column (75 µm inner diameter, 350 
µm outer diameter) packed with C18 resin (ReproSil, Pur C18AQ 3 µm, Dr. Maisch, 
Germany). Solvent A was 0.1% FA and 5% ACN in ddH2O and solvent B was 95% ACN 
with 0.1% FA. Sample was injected in an aqueous solution at a flow rate of 500 nl/min. 
Peptides were separated with a gradient of 0-36% over 120 min followed by a gradient of 
36-60% for 10 min 60-80% over 5 min at a flow rate of 250 nl/min. For histones, liquid 
chromatography separation was performed with a gradient of 0-40% solvent B over 90 min 
followed by a gradient of 40-60% for 10 min and 60-80% over 5 min at a flow rate of 250 
nl/min. The nanoelectrospray ion source (Proxeon, Odense, Denmark) was used with a 
spray voltage of 2.4 kV. No sheath, sweep and auxiliary gasses were used and capillary 
temperature was set to 190 °C. The mass spectrometer was operated in data-dependent 
mode to automatically switch between MS and MS/MS acquisition. In the LTQ-FT Ultra, 
full scan MS spectra (200-1650 m/z) were acquired with a resolution of 100,000 (FWHM) 
at 400 m/z setting an AGC target of 1,000,000. The five most intense ions were isolated for 
fragmentation in the linear ion trap using collision-induced dissociation (CID) at a target 
value of 5,000. Singly charged precursor ions were excluded. Collision gas pressure was 
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1.3 millitorrs and normalized collision energy using wide band activation mode was 35%. 
Ion selection threshold was 250 counts with an activation q=0.25. The activation time of 30 
ms was applied in MS2 acquisitions.  
4.8 Quantitative MS analysis of hPTMs co-enriched in precipitated chromatin  
Raw data from LTQ-FT Ultra were converted to mgf files using Raw2MSM 
software (version 1.10) (157). MS/MS spectra were searched with Mascot Daemon 
(version 2.2.2, Matrix Science) against the IPI human database (version 3.68, 87,061 
entries). MS mass tolerance was set to 10 ppm and MS/MS mass tolerance was set to 0.5 
Da. Chemical alkylation with D6-acetic anhydride, which labels unmodified and mono-
methylated Lysines with a deuterated acetyl moiety but does not react with di-methyl, tri-
methyl and acetyl Lysines, results in a delta mass of 45.0294 amu for each D3-acetyl group 
added and thus allows to unambiguously distinguish isobaric modified peptides by their 
different LC retention times. The search included variable modifications: Lysines D3-
acetylation (+45.0294 Da), Lysine mono-methylation (calculated as the sum of the masses 
of D3-acetylation (+45.0294) and mono-methylation (+14.016 Da)), di-methylation (+ 
28.031 Da), tri-methylation (+42.046 Da), Lysine acetylation (+42.010 Da), Methionine 
oxidation (+15.995 Da) and N-terminal protein acetylation (+42.010 Da). Low-confidence 
peptide identifications were filtered from Mascot results according to following criteria: 
peptides with either ion score lower than 15 or more than 5 putative PTMs were removed 
(100); redundant peptides with same ID were filtered out by selecting the peptide with the 
highest Mascot score. Extracted ion chromatograms (XIC) were constructed for each 
precursor based on the m/z value, using a mass tolerance 10 ppm and a mass precision up 
to 4 decimals. Histone PTMs were first quantified by calculating the area under the curve 
(AUC) of each peak corresponding to every specific modified peptide. Then, their relative 
abundance was estimated by dividing the area under the curve (AUC) of each peptide by 
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the sum of the areas corresponding to all observed modified forms of that peptide [(XIC 
modified peak/∑ XIC all peaks)x100)]. Modification enrichment was calculated as the 
ratio between the relative abundance in the ChIP-ed octamer and the corresponding 
relative abundance estimated from input. Peptides containing modifications were validated 
by manual annotation of MS/MS spectra (see Appendix I and II for peptide (3-8) and (9-
17) of histone H3), using the QualBrowser version 2.0.7 (ThermoFisher Scientific).  
4.8.1  Masses (in Da) of site-specific identification of PTMs on Histone H3 
Peptide 3-8: TKQTAR, K4unmod=375.2208, K4me1= 382.2286, K4me2= 366.7218, 
K4me3=373.7296; peptide 9-17: KSTGGKAPR, K9unmod=496.2937, 
K9me1=503.3016, K9me2=487.7947, K9me3=494.8025, K9unmod/K14Ac=494.7843, 
K9me1/K14Ac=501.7921, K9me2/K14Ac=486.2853, K9me3/K14Ac=493.2931, 
K9Ac/K14Ac=493.2749; peptide 18-23: KQLATKAAR, K18/23unmod=538.8383, 
K18me1/K23unmod=545.8461, K18unmod/K23Ac or K18unmod/K23Ac=537.3289, 
K18me1/K23Ac=544.3367, K18Ac/K23Ac=535.8195; peptide 27-40: 
KSAPATGGVKKPHR, K27/36/37unmod=784.9645, K27me1 or K36me1=791.9723, 
K27me2 or K36me2=776.4655, K27me3 or K27me2/K36me1 or 
K36me2/K27me1=783.4733, K27me1/K36me1=798.9802, 
K27me2/K36me2=767.9664, K27me3/K36me1=790.4811; peptide 73-83: 
EIAQDFKTDLR, K79unmod=690.8635, K79me1=697.8713, K79me2=682.3644.  
4.8.2. Masses (in Da) of site-specific identification of PTMs on Histone H2A 
peptide 4-11: GKQGGKAR, K5/9unmod=446.2675, KAc=444.7581, Kdi-
Ac=443.2487. 
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4.8.3. Masses (in Da) of site-specific identification of PTMs on Histone H4 
peptide 4-17: GKGGKGLGKGGAKR, K5/K8/K12/K16unmod=725.9476, 
KAc=724.4381, Kdi-Ac=722.9287, Ktri-Ac =721.4193, Ktetra-Ac=719.9099.  
4.9 Proteomic analysis of proteins co-associated within precipitated chromatin fractions  
Protein interactors from the X-ChIPs were identified and quantified using 
MaxQuant software (158) (version 1.1.1.36). MS/MS spectra were recorded in “centroid” 
mode and the six most abundant peaks per 100 Da mass intervals were selected for search. 
Filtered MS/MS spectra were searched against the IPI human database (version 3.68, 
87,061 entries), combined with the standard MaxQuant contaminants database, by 
Andromeda search engine (159, 160). MaxQuant analysis included an initial search with a 
precursor mass tolerance of 20 ppm, whose results were used for subsequent mass 
recalibration (161). Enzyme specificity was set to trypsin, allowing two misscleaveges and 
cleavage at the N-terminus of Proline. Peptide identification was based on a search with 
mass deviation of the precursor ion of 6 ppm and the fragment mass tolerance was set to 
0.5 Da. The mass accuracy of the precursor ions was improved by the time-dependent 
recalibration. MaxQuant was employed to filter identifications at 1% false discovery rate 
(FDR) at three levels, namely: site, peptide, and protein. Carbamidomethylation of 
Cysteine was selected as a fixed modification whereas oxidation of Methionine, and 
acetylation of protein N-terminus were included as variable modifications. The 
modifications corresponding to Arginine and Lysine labeled with heavy stable isotopes are 
treated as fixed modifications in the Andromeda search. Additional peptides were 
identified by "the match between run" option in MaxQuant, which matches precursor 
masses in a 2-min retention time window (after realignment of the runs) based on the 
accurate mass measurement. Proteins were accepted if identified with at least two peptides 
one of which unique. Protein ratios were normalized by standard deviation; complete 
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output tables for the H3K9me3 and H3K4me3 chromatomes are provided in Appendix IV 
and V, respectively. Analysis and visualization of the data were performed using the open-
source package R with in-house scripts and Perseus program (J. Cox, manuscript in 
preparation or www.maxquant.org). 
4.10 Quantitative RT-PCR of immunopurified DNA  
DNA from ChIP-ed material was eluted in TE (Tris-HCl pH 7.5, EDTA) containing 
2% SDS for 15minutes at 65°C (for X-ChIP experiments DNA was also de-crosslinked at 
65°C overnight) and DNA was then purified through Qiaquick columns (QUIAGEN). 1µl 
of purified DNA was used for substrate for amplification on Applied Biosystems 7500 Fast 
Real-time PCR system applying Biosystem Sybr-green). 
3.10.1 Primers for quantitative PCR upon conventional ChIP: 
AP945 (chr4:57142864(start)-57142927(end)) 
Forward primer: 5´-CGCTACTGTTGGGTGCTGG-3´ 
Reverse primer: 5´-GCCTGGAAAGCTGTATTTGCTG-3´ 
 
AP777 (chr2:198189648(start)-198189843(end))  
Forward: 5´-TCCATCACGTGCGACGC-3´  
Reverse: 5´-GAGGCGCGGTATCCCAG-3´ 
 
α-Repeats Regions  
Forward primer: 5´-CTCAGTAACTTCCTTGTGTTGTG-3´  
Reverse primer: 5´-ATTCTGTCTAGTTTCTATAAGAAG-3´ 
63 
 
 4.11 Immunoblot analysis 
Input chromatin and immunoprecipitated histone octamers were separated in 17.5% 
SDS-PAGE and transferred to PVDF membranes (Millipore). Membranes were blocked 1 
h in 5% milk in TBS supplemented with 0.1% Tween (TBS-T). After blocking, membranes 
were incubated at 4°C for an overnight with primary antibodies specific for histone 
modifications, diluted in TBS-T 5% milk.  After three washes in TBS-T, binding was 
revealed by ECL Plus® Immunoblotting Detection System (Amersham Biosciences); 
antibodies against the unmodified version of both H3 and H4 were used as loading control. 
For Western blot analysis the following antibodies were used, according to the 
manufacturer’s instructions: H3K9me3 (Abcam 8898, dilution 1:1000), H3K36me2 
(Abcam 9049, dilution 1:1000), H3K27me3 (Upstate Millipore 07-449, dilution 1:2500), 
H3K4me3 (Active Motif 39159, dilution 1:1000), H4K20me3 (Abcam 9053, dilution 
1:1000), acetyl-Histone H4 (Upstate Millipore 06-866, dilution 1:2000) where K5/8/12/16 
were acetylated, H3K79me2 (Abcam 3594-00, dilution 1:1000), acetyl-Histone H3 
(Upstate 05-599, dilution 1:5000) where K9/14 were acetylated, H3K18me1 (Active Motif 
39667, dilution 1:500), Histone H2A.X (phospho Tyr142) (Upstate Millipore 07-1590, 
dilution 1:100; Abcam 94602, dilution 1µg/µl), phospho-Histone H2A.X (Ser139) 
(Millipore 05-636, dilution 1:1000), histone H2A.X (Abcam 11175, dilution 1:5000), 
histone H3.3 (Abcam ab62642, dilution 1:1000), unmodified histone H3 (Abcam 1791, 
dilution 1:5000), unmodified histone H4 (Millipore Upstate 07-108, dilution 1:1000). 
4.12 Immunofluorescence analysis 
Cells grown on coverslips were washed twice with PBS, fixed with 4% para-
formaldehyde for 20 min, permeabilized in 0.5% Triton X-100 in PBS for 5 min and then 
blocked in 10% BSA for 1 h. Cells were subsequently probed with the following mix of 
antibodies: WSTF (Sigma W3516, dilution 1:250) and HP1β (Millipore MAB34448, 
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dilution 1:500); H3K9me3 (Abcam 8898, dilution 1:500) and HP1β. After 1 h of primary 
antibody incubation, cells were washed three times with PBS and then incubated with 
either a-rabbit secondary antibody conjugated with Cy3 (diluted 1:800), or with a-rabbit 
secondary antibody conjugated with fluorescein isothiocyanate (FITC-conjugate), diluted 
1:50. DNA was stained with DAPI, diluted 1:5000 in PBS, for 15 sec. Slides were 
mounted in Mowiol and images were acquired using a wide field Olympus Biosystem 
Microscope BX51.  
4.13 ChIP-Sequencing: preparation of ChIP DNA libraries, sequencing and data 
analysis 
ChIP DNA was prepared for Solexa 2G sequencing using a standard protocol. 
ChIP-ed DNA was treated to remove 3’ overhangs and fill in 5’ overhangs resulted in blunt 
ended DNA fragments. An A residue was added by terminal transferase to the 3’ end and 
the resulting fragments were ligated with Illumina adapters. The resulting Adapter-
modified DNA fragments were separated by agarose gel electrophoresis and the band 
between 120-200 bp was excised and the DNA fragments were extracted using a Qiaquick 
Gel Extraction Kit (Qiagen Inc). The specific DNA fragments were subjected to 18 cycles 
of PCR amplification; amplified fragments were then gel purified from an excess of PCR 
primers, using Qiagen columns. The DNA fragment library was quantified with 
Bioanalyzer using High Sensitivity Chip, diluted to a 10 nM working stock concentration 
for cluster generation. Finally, cluster generation was performed according to standard 
protocols of the manufacturer (Illumina) and loaded into individual lanes of a flow cell (4 
picomoles/sample). ChIP-Seq data were acquired with the Illumina Genome Analyzer II, 
producing a fixed 36bp read length. After each base incorporation step, the flow cell 
surface was washed to remove reactants and then imaged by microscope objective. For the 
analysis of sequencing Illumina data, read tags passing standard Illumina quality filter 
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(Failed-chastity < 0.6) were aligned to hg18 genome using BWA 0.5.9 with default 
parameters (162). H2AX data and  H3K9me3 and H3K4me3 ChIP-Seq data from (147), 
stored in the NCBI GEO SuperSeries GSE20303, were analyzed with dspchip 
0.8.5 (http://code.google.com/p/dspchip). Non-duplicated tags with mapping quality higher 
than 15 were retained; normalized profile of IP data were subtracted from the Input; the 
resulting profile was processed using a Hanning Window low-pass filter (window size: 500 
kbp) and negative values were removed. Correlations between ChIP profiles were 
calculated with wigCorrelate from UCSC Genome Browser utilities.  
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5. RESULTS 
5.1 Characterization of hPTM patterns co-enriched at specific chromatin regions by N-
ChIP combined with high resolution MS analysis  
Chromatin Immunoprecipitation enables profiling of the localization of a protein or 
a histone modification along the genome by deep sequencing. In a proteomics equivalent 
of such an experiment, ChIP is followed by the analysis of the immunopurified proteins by 
MS. We established a preparative version of the classical “Native ChIP” (N-ChIP, namely 
ChIP without crosslinking) to purify chromatin regions enriched in a specific histone 
modification, in order to characterize by MS the hPTMs patterns and proteins associating 
with such regions. We investigated fractions enriched in silent or active chromatin by 
taking advantage of the well-characterized enrichment of H3K9me3 at both pericentric 
heterochromatin and repressed euchromatic genes, and of H3K4me3 in active promoters. 
The protocol is outlined in figure 16A. Briefly, chromatin from HeLaS3 cells was digested 
with MNase to obtain a first soluble fraction (S1), comprising small fragments (mono-, di-
nucleosomes), and a second soluble fraction (S2), comprising large fragments (tri- to epta-
nucleosomes) (Figure 16B, left panel). The fraction enriched in mono-nucleosomes (Figure 
16B, right panel) was incubated with antibodies recognizing either H3K9me3 or 
H3K4me3. For immunoprecipitation we chose two antibodies widely employed by the 
community for ChIP-Seq studies, with proved specificity and efficiency (163, 164). 
Control ChIP was chromatin input not incubated with antibody. Immunopurified chromatin 
was captured on magnetic beads and the extracted proteins were separated by SDS-PAGE 
(Figure 16C). Each core histone from the fractionated nucleosomes was analyzed by LC-
MS/MS.  
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Figure 16. Scheme of the N-ChroP strategy, combining N-ChIP and MS analysis. A) 
Scheme of the experimental approach. B) DNA isolated after digestion with micrococcal 
nuclease S7 (MNase), separated in fractions containing mono- (S1) or poly-nucleosome 
(S2) (left panel) and chromatin input (right panel), resolved on a 1% agarose gel stained 
with ethidium bromide. C) SDS-PAGE of ChIP-ed S1 fraction: core histones H3, H4, H2A 
and H2B are visible around and below the 17kDa band of the pre-stained protein marker, 
with H3 and H2B co-migrating. 
                           
     
A) 
B) C) 
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Histone PTMs were first identified and then quantified by calculating the area 
under the curve (AUC) of each peak corresponding to every specific modified peptide 
(Figure 17). Then, their relative abundance was estimated, both in the Input and in the 
ChIP, by dividing the area under the curve (AUC) of each peptide by the sum of the areas 
corresponding to all observed modified forms of that peptide. Modification enrichment was 
calculated as the ratio between the relative abundance in the ChIP-ed octamer and the 
corresponding relative abundance estimated from input. 
 
Figure 17. Representative scheme of hPTMs analysis. Zoomed mass spectra for the 2+ 
charge of the unmodified, mono-, di-, and tri-methylated K9, for Input and ChIP, and 
extracted ion chromatograms (XIC) constructed for each precursor at the corresponding 
m/z value for the same samples.  
 
 
                 
 
The analysis first focused on histone H3 (9-17) and (3-8) peptides: a specific enrichment of 
K9me3, as well as K4me3, associated with the depletion of unmodified H3 and H3 mono-
methylated at K9 and K4, demonstrated the efficiency and specificity of the ChIP with the 
respective antibody (18A). The depletion of acetylated H3K9/K14 was also observed in 
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H3K9me3-nucleosomes (Figure 18A). Western blot (WB) analysis confirmed the 
enrichment of K9me3 and K4me3 obtained at MS level (Figure 18B).  
 
Figure 18. Validation of the N-ChroP approach. A) Relative enrichment of K9me3 (co-
existing or not with acetylated K14) and K4me3, in peptides (9-17) and (3-8) of H3, 
respectively. The results were obtained upon N-ChIP using antibodies α-H3K9me3 and α-
H3K4me3 (#1 and #2 indicate two replicates). The enrichment is expressed as a log2 Ratio 
of the relative abundance of each methylation in the ChIP sample as compared to input and 
represents the averages ± SEM (Standard error of the mean) from three independent 
experiments. B) WB validation of H3K9me3 and H3K4me3 enrichment in the 
corresponding ChIPs: an aliquot of ChIP-ed material and of Input were loaded on SDS-
PAGE, and immunoblotted with antibodies H3K9me3 and H3K4me3. 0.2 % and 0.04% of 
input were loaded for H3K9me3 and H3K4me3, respectively, for a semi-quantitative 
comparison with IP. Unmodified H3 is the loading control.  
                                 
                             
                                                       
 
The potential cross-reactivity of the anti-H3K9me3 antibody with other methyl Lysines 
was excluded with a competition assay where the chromatin was incubated with antibody 
α-H3K9me3 in the presence of an excess of different soluble peptides bearing the 
following modifications: K9me2, K4me3, K27me3 in H3 and K20me3 in H4. Unspecific 
A) 
B) 
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recognition of other Kme was excluded, except for K9me2, where a mild binding was 
detected (Figure 19A). The comparison between H3K9me3 abundance in flow-through and 
input demonstrated that about 50% of the chromatin regions of interest were captured in 
the ChIP, ruling out a potential bias due to the enrichment of only a sub-fraction of 
chromatin (Figure 19B). 
 
Figure 19. Evaluation of H3K9me3 antibody specificity and efficiency. A) Competition 
assays for antibody specificity test: after MNase digestion chromatin is incubated with 
H3K9me3 antibody with or without excess (150X) of different soluble peptides bearing 
methylations at distinct sites (H3K9me3, H3K9me2, H3K4me3, H3K27me3 and 
H4K20me3): immunoprecipitated materials are separated by SDS-PAGE and stained with 
Colloidal Comassie blue. B) Relative enrichment of unmodified, mono-, di-, and tri-
methylated K9 in flow-through (FT) as compared to input (IN). Histogram represents the 
averages ± SEM from three independent experiments and results in significant depletion of 
K9me3 and K9me2 in FT.  
 
 
              
 
 
 
A) B) 
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5.2 Label free quantification of histone PTMs enriched in repressed and active 
chromatin domains 
The hPTMs enriched in silent and active chromatin domains are summarized in the 
heatmap and histograms (Figure 20).  
 
Figure 20. Relative enrichment of modifications in H3K9me3 and H3K4me3 
mononucleosome. Heatmap of hPTMs enrichment for all the modified resides identified 
on H3, H4 and H2A histones. Each row corresponds to a distinct histone modification, 
whereas columns correspond to the different antibodies used for the ChIP (n.d. means not 
detected). 
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Focusing on the modifications associated on histone 3, our analysis on intact native 
nucleosomes validated the selectivity of our antibodies and overall recapitulated the 
“chromatin canonical states” described by Ernst and Kellis and based on a meta-analysis of 
a large set of data (165). In particular, H3K4me1 was found depleted in H3K9me3 
nucleosomes (Figure 21A), since K4me1 is preferentially associated with hyperacetylated 
H3 and never observed in combination with H3K9me3; proving that H3K4me1, likewise 
H3K4me2 and H3K4me3, occurs mostly in transcriptionally active chromatin (108). In 
addition, we observed a depletion of K9 methylations and a parallel increase of K14ac and 
K9ac/K14ac in H3K4me3-euchromatin (Figure 21B), in line with genome-wide 
localization studies showing that H3K4me3 marks active promoters in human cells, with a 
pattern very similar to H3K9ac/K14ac (166).      
    
Figure 21. Relative enrichment of modifications in (3-8) and (9-17) peptides of H3 in 
H3K9me3 and H3K4me3 ChIPs. A) Relative enrichment of K4 methylations with α-
H3K9me3. B) Relative enrichment of K9 methylations with α-H3K4me3. Relative 
enrichment of each PTM is expressed as a log2 Ratio, as previously described. 
 
 
 
 
A) B) 
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H3R26me2, in association with K23Ac, was found enriched in H3K4me3 domains 
(Figure 22A and 22B): information on Arginine methylations is overall partial, however 
emerging evidence suggests that H3R26me2 may antagonize Polycomb repression due its 
proximity to K27 (167, 168).  
We found H3K18me1 enriched in silent domains and depleted in active ones 
(Figure 23A and 23B). Indeed, a silencing role for this mark had been already proposed, 
based on two observations: first, its half-maximal life was reported as significantly lower 
than other mono-methylations with gene-activating function (105); second, it could be 
antagonizes K18ac, an active mark (169). 
 
Figure 22. Identification of R26me2 in H3K4me3 regions, enriched by N-ChIP. A) 
Relative enrichment of R26me2 in (18-26) peptide of H3, upon N-ChIP using antibody α-
H3K4me3. Relative enrichment is expressed as a log2 Ratio, as previously described. B) 
MS/MS spectra of H3 (18-26) peptide containing R26 di-methylated. 
 
  
 
 
 
 
 
 
A) B) 
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Figure 23. Relative enrichment of modifications on (18-23) peptides of H3 in H3K9me3 
and H3K4me3 ChIPs. A) Relative enrichment of K18 and K23 methylation and 
acetylation in H3K9me3 and H3K4me3-enriched domains. Relative enrichment of each 
PTM is expressed as a log2 Ratio, as previously described. B) WB validation of 
H3K18me1 enrichment in the H3K9me3 ChIP. Antibodies against H3K9me3 and 
H3K4me3 are used to verify the effective enrichment of specific modifications in the 
corresponding IPs, and unmodified H3 is the loading control.  
 
                            
     
A) 
B) 
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Analysis of methylation profiles on peptide H3 (27-40) identified several distinct 
modified peptides. The chemical alkylation with D6-acetic anhydride, which labels 
unmodified and mono-methylated Lysines with a deuterated acetyl moiety but does not 
react with di-methyl, tri-methyl and acetyl Lysines, allowed distinguishing different 
methylations on K27 and on K36/37. In a case where two of these Lysines are mono-
methylated, it would be challenging to distinguish this species from an isobaric peptide 
containing a single di-methylation modification (Figure 24A). The derivatization approach 
however can remove this isobaric property (Figure 24B). The addition of the deuterated 
acetyl moiety to unmodified and mono-methylated Lysines leads to a mass difference 
between the two peptide-forms. Furthermore, the nature of this modification permits 
specific assignment to Lysines, for example in the case of K27 and K36. These properties 
are displayed in the shifted elution profile (Figure 24A and 24B). 
 
76 
 
Figure 24. Elution profile of H3 (27-40) modified peptide. A) Extracted ion 
chromatograms (XIC) of various 2+ charge modified forms relative to H3(27-40) peptide 
are reported, upon Arg-C digestion, for the time range corresponding to 20-34 min. Peptide 
ions at the specific m/z values correspond  to unmodified, mono- (me1), di- (me2) and tri-
(me3) methylated  H3(27-40) peptides, respectively. B) Extracted ion chromatograms 
(XIC) of various 2+ charge modified forms relative to H3(27-40) peptide are reported, 
upon deuterated acetic anhydride alkylation, prior to trypsin digestion, for the time range 
corresponding to 36-50 min. Peptide ions at the specific m/z values correspond to 
unmodified, mono-(me1), di-(me2) and tri-(me3) methylated H3(27-40) peptides, 
respectively. Peptide ion at 798.9802 m/z is assigned to mono-methylations at K27 and 
K36. Based on the number of D3-acetyl groups and methylations, distinct modification 
degrees at specific Lysines residues can be assigned unambiguously. Furthermore, with 
this strategy certain isobaric peptides (i.e. K27me2 and K36me2) can be efficiently 
resolved during chromatography by their distinct elution times.  
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Quantitative analysis showed that H3K27me1 was enriched in heterochromatin 
(Figure 25A), confirming previous studies where constitutive heterochromatin was 
characterized by the focal enrichment of H3K9me3 and H3K27me1 (170). H3K27me3 was 
slightly enriched in heterochromatin and depleted in euchromatin, as previously described 
(Figure 25A and 25C) (42).  
As expected, H3K79me1/me2 were depleted in H3K9me3 while significantly 
increased in H3K4me3 domains (Figure 25B and 25C); indeed H3K79 methylation is 
proposed to mark active, or at least accessible, genes and to function as a barrier to 
heterochromatin spreading (171).  
Overall, the confirmation of previously described or predicted PTMs synergisms 
confirmed the robustness of the newly established strategy and thus corroborated the 
discovery of novel associations among histone marks, both intra-molecularly and inter-
molecularly within the immunopurified nucleosomes. For instance, we observed that di-
methylated K36 is depleted in both chromatin domains (Figure 25A and 25C): the 
unexpected underrepresentation of this mark in H3K4me3 regions can be explained by 
reasoning that H3K4me3 is typically enriched at proximal promoters whereas 
H3K36me2/3 associate with gene elongation and thus are highly overrepresented at the 3´ 
of genes (172, 173): as such, this evidence further corroborates the high resolution of our 
analysis in dissecting PTMs clustering at a single nucleosome level.   
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Figure 25. Relative enrichment of modifications on (27-40) and (73-83)  peptides of H3 
in H3K9me3 and H3K4me3 ChIPs. A) Relative enrichment of K27 and K36 (A) as well 
as K79 (B) methylations in H3K9me3 and H3K4me3-enriched domains. Relative 
enrichment of each PTM is expressed aas log2 Ratio, as previously described. C) WB 
validation of specific Lysine methylations enrichment in the both ChIPs (#1 and #2 
indicate two replicates): antibodies α-H3K27me3, K79me2 and K36me2 were used. 
Unmodified H3 is the loading control.  
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We then extended the study to the PTMs on the co-purified histone H2A and H4: 
acetylations on the H2A N-terminus were reduced in the H3K9me3-domains and enriched 
in H3K4me3-regions (Figure 26A); similarly, hyper acetylated H4 was found enriched in 
euchromatin (Figure 26B and 26C) (3). Methylation at Lysine 20 of H4 was over-
represented in H3K9me3-domains while reduced in H3K4me3-domains, as detected by 
WB (Figure 26C): in fact H4K20me3 follows H3K9 methylation during initiation of a 
heterochromatic environment (174).  
 
Figure 26. Relative enrichment of modifications on (4-11) peptide of H2A and on (4-17) 
peptide of H4 in H3K9me3 and H3K4me3 ChIPs. A) Relative enrichment of H2A (A) 
and H4 (B) Lysines acetylation in H3K9me3 and H3K4me3-enriched domains (#1 and #2 
indicate two replicates). Relative enrichment of each PTM is expressed as a log2 Ratio 
Relative enrichment of each PTM is expressed as a log2 Ratio, as previously described. C) 
WB validation of H2A and H4 acetylation enrichment in H3K4me3 ChIP (right panel) and 
H4K20me3 enrichment in H3K9me3 ChIP (left panel). 
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In conclusion, our approach indicates that ‘‘active’’ modifications (methylated K4, 
K36, K79, acetylated K9/K14, K18/K23 of H3 and hyper acetylated H2A and H4) are 
enriched in H3K4me3 domains, whereas ‘‘silent’’ modifications (methylated K9, K27 of 
H3 and K20 of H4) are overrepresented in H3K9me3 territories (42, 108, 175).  
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5.3 Large-scale study of chromatin-associated proteins by X-ChIP combined with high 
resolution MS analysis 
To characterize H3K9me3 and H3K4me3-interacting proteins we modified the 
crosslinking ChIP protocol to adapt it for SILAC-based quantitative interactomics (88). 
The protocol is outlined in figure 27A: HeLaS3 cells grown in “light” and “heavy” media 
were fixed with formaldehyde and chromatin was subjected to sonication to generate 300-
500bp lengths of DNA fragments (Figure 27B). Both isotope-coded samples (heavy H and 
light L) were incubated with specific antibodies; in one of the two isotope-channels the 
antibody was saturated with an excess of soluble H3 peptide bearing the modification used 
as bait (either H3K9me3 or H3K4me3). All nucleosomes exposing those PTMs were 
competed out, as well as all co-associating proteins; unspecific proteins, instead, were not 
selectively competed. Two replicates of the X-ChIP were performed swapping the H and L 
channels in which the peptide-competition control was carried out (the so-called “forward” 
and “reverse” format), to increase the discriminating potential of the approach: in the 
forward experiment we incubated the specific antibody with a heavy (H)-labelled 
chromatin preparation while the excess of soluble peptide was added to the light (L)-
labelled chromatin input; in the “reverse” format the two samples were inverted.  
After incubation, the H and L immunopurified chromatins were pooled and 
extracted proteins were separated by SDS-PAGE (Figure 27C).  
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Figure 27. Scheme of the X-ChroP strategy, combining X-ChIP and SILAC 
quantitation. A) Scheme of the experimental approach. B) DNA isolated after shearing by 
sonication, resolved on a 1.3% agarose gel and stained with ethidium bromide. The sample 
prepared for X-ChIP usually contains fragments of 300-500bp. C) SDS-PAGE of co-
immunoprecipitated proteins: lanes were sliced in ten pieces, digested with trypsin and 
analyzed by LC-MS/MS.             
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Samples were subjected to trypsin digestion, followed by MS analysis. Proteins 
were identified and quantified by the MaxQuant software (158). Using a confidence level 
of 99% (protein FDR 1%), 637 and 381 proteins were identified in the H3K9me3 and 
H3K4me3 X-ChIPs, respectively (Figure 28A and 28B). 
 
Figure 28. Proteins identified and quantified in H3K9me3 and H3K4mee3 ChIPs. A) 
Venn Diagrams show the overlap of identified and quantified proteins (Ratio Count 
(RC)≥1) in two experimental replicates of ChIPs for the modification of interest: 
H3K9me3 (left) and H3K4me3 (right), respectively (For=Forward, Rev=Reverse). B) 
Table of identified and quantified proteins for H3K9me3 and H3K4me3 X-ChIPs. 
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The specific enrichment of the modifications used as bait (H3K9me3 and 
H3K4me3), together with the corresponding depletion of the unmodified and mono-
methylated forms, confirmed the efficiency and specificity of the X-ChIP (Figure 29A, 
29B and 29C). 
 
Figure 29. Validation of the X-ChroP approach. A) Zoomed mass spectra for the 2+ 
charge state of the H3K9me2 and H3K9me3 peptides (9-17), in both light and heavy forms 
(upper panel) and extracted ion chromatograms (XIC) constructed for each precursor m/z 
value (lower panel). B) Relative enrichment of K9me3 after H3K9me3 X-ChIP at MS 
level. C) Validation of H3K4me3 enrichment in the corresponding Forward (For) and 
Reverse (Rev) X-ChIPs: aliquot of ChIP-ed and input samples were probed with α-
H3K4me3 antibody. Unmodified H3 is used as loading control.  
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A log2 plot of the H/L ratios of the two sets of identified proteins from forward and 
reverse experiments allowed unambiguous identification of binders (Figure 30A and 30B 
for H3K9me3 and H3K4me3, respectively). 
 
Figure 30. The heterochromatome and euchromatome identified with the X-ChroP. 
Proteins are plotted by their SILAC-ratios in the first (x axis) and second (y axis) SILAC 
experiment for H3K9me3 (A) and H3K4me3 (B) (For=Forward, Rev=Reverse). Speciﬁc 
interactors should lie in the upper right quadrant enlarged, close to the diagonal. Red, 
dotted lines represents the cutoffs, selecting the top 40% and 30% of protein. In Blue are 
highlighted already annotated specific interactors, in green the histone variants and 
inorange/violet proteins associated with heterochromatin.  
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The overall spread distribution of the SILAC ratios observed in the scatter plots can 
be explained by the fact that completely independent cells and chromatin preparations were 
used as input for each X-ChIP in the “forward’ and “reverse” experiments, which thus 
represent full biological replicates, resulting in increased variability. Yet, specific 
interactors could be selectively distinguished based on their SILAC H/L ratios (H/L>1 in 
the forward and H/L<1 in the reverse experiment, upper right quadrant of the scatter plot) 
from the background proteins, which have a constant ratio close to 1. In particular, we 
considered a protein to be specifically enriched when present in the top 40% of proteins 
with H/L ratios >1, a filter that, selected 214 and 100 interactors for H3K9me3 and 
H3K4me3, respectively (Figure 31A and 31B), among which we found several well known 
K9me3 and K4me3 binders. For the biological follow-up of novel interactors, we however 
chose even higher stringency and focused on proteins present in the top 20% of the ratios.  
 
Figure 31. Features of the H3K4me3 and H3K9me3 interactomes.  A) Protein ratio 
distribution for the H3K9me3 ChIP Forward (For) and Reverse (Rev) experiments. Venn 
Diagrams of Top 40% of protein ratios for two H3K9me3 X-ChIP replicates, with 71% 
overlap. B) Protein ratio distribution for the H3K4me3 ChIP For and Rev experiments. 
Venn Diagrams of Top 40% of protein ratios for two H3K4me3 replicates, with 65% 
overlap. 
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5.4 X-ChroP characterizes novel players in H3K9me3 and H3K4me3 chromatomes 
Several of the top 40% heterochromatic interactors were previously ascribed to this 
region by independent biochemical experiments and were our positive controls (see table 
in Appendix IV): the three isoforms (α, β, γ) of heterochromatin protein 1 (HP1) (176), 
CDYL1 (177), SETDB1, the euchromatic HMT of the Suv39 family that tri-methylates 
H3K9 (178, 179), the DNMT1 (180); and its interactor  UHRF1 (181), whose recognition 
of H3K9me3 is inhibited when by the acetylation of the same residue (181). RIF1, whose 
localization to a subset of replicating pericentromeric heterochromatin has been described 
(182). In addition to direct H3K9me3 binders, our approach also enabled the identification 
of novel and probably indirect interactions among heterochromatic proteins: for instance, 
we detected the HP1-associated proteins ADNP and POGZ (183, 184) and KDM2A, a 
H3K36 demethylase that associates indirectly to heterochromatin by HP1 binding (148, 
185, 186).  
In the H3K4me3 chromatome (see table in Appendix V) we identified Spindlin1 
(148) and the subunits of the MLL-complexes WDR5, RbPB5 and ASH2 (187, 188). 
Furthermore, our screening confirmed various proteins also identified by Vermeulen with 
the SILAC peptide-pull downs, such as BPTF (189), IWS1 (190), PHF2 and various TBP-
associated factors (TAFs) of the TFIID complex (88). 
These results overall confirmed the robustness of our approach and allowed 
screening for novel interactors with higher confidence. Among the newly identified 
heterochromatin components (Table in Appendix IV), we found heterochromatin protein 1-
binding protein 3 (HP1-BP74) (191). Since the role of HP1-BP74 is still elusive, our result 
suggests a potential role in formation and/or maintenance of the compacted chromatin 
structure, through HP1 binding. We also identified different scaffold attachment factors 
(SAFs) including SAFB1, SAFB2 and SAFA, which bind the AT-rich scaffold/matrix 
attachment regions (S/MARs) of DNA through their scaffold attachment factor-box (SAF-
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Box) (192). Other members of the family found in the H3K9me3 interactome are: SAFB-
like transcriptional modulator (SLTM) (193) and Matrin3 (MATR3), shown to bind to 
S/MARs and to localize in heterochromatin regions, similarly to SAFA (194, 195). With 
this as a basis, SAFB proteins could have a role in higher order heterochromatin 
organization, by interacting with chromatin remodeling complexes, to achieve a more 
compact structure.  
Among novel H3K4me3-interactors we identified the FACT (facilitates chromatin 
transcription) complex, a heterodimer composed of two subunits of 140kDa and 80kDa 
(196). FACT is essential for Pol II-driven transcription on chromatin templates (196) and it 
has an intrinsic histone chaperone activity to reassemble histones onto DNA (197). In 
addition, FACT seems to be associated with actively transcribed Pol II genes in Drosophila 
(198) and in Arabidopsis FACT co-localizes with actively transcribed genes, whereas it 
seems excluded by heterochromatin and intragenic regions (199).  
When directly comparing the chromatomes of silent and active chromatin we 
interestingly observed also minor subset of proteins equally, yet specifically, enriched in 
both fractions (Figure 32): for instance, SMARCC2 and SMARCA5, subunits of the ATP-
dependent chromatin remodeling complex SWI/SNF (200) and HMGB2, a member of the 
high mobility-group family, (201). In addition, we identified various structural components 
of chromatin, with functions in chromosome condensation and separation, such as SCC112 
that binds the Cohesin complex and associates with chromatin throughout the cell cycle, 
regulating sister chromatid cohesion during mitosis (202-204). Interestingly, the vast 
majority of these proteins homogeneously distributed exert more universal structural roles 
in chromatin homeostasis and dynamics, processes not linked to the transcriptional state. 
This may be suggestive of similar roles for those proteins in the same class whose function 
is still uncharacterized. 
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Figure 32. Proteins in common between the H3K9me3 and H3K4me3 interactomes. 
Chromatin purifications identify both distinct and common sets of proteins in the 
H3K4me3 and H3K9me3 interactomes: Venn diagrams show numbers of proteins 
identified and enriched (Ratio ≥ 1) in both data sets (upper) and present in the top 40% of 
proteins ratios (lower).  
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5.5 Accumulation of histone variants at specific chromatin domains 
A great advantage offered by the ChroP approach in respect to other strategies is 
the possibility to characterize histone variants enriched at specific chromatin domains:  
histone macro-H2A.1 (mH2A1), was found among the top 20% interactors of H3K9me3 
chromatin suggesting its prevalent heterochromatic localization (Figure 33A), in line with 
evidences of a putative structural role of this variant in organizing constitutive 
heterochromatin (205, 206). 
The H3.3 variant was instead overrepresented in the H3K4me3 regions (Figure 33B 
and Figure 33C). H3.3 is incorporated into chromatin in a replication-independent manner 
upon chromatin assembly following active transcription of genes; consequently it localizes 
mainly at the promoters of active genes, it is decorated by active marks and contributes to 
the epigenetic memory maintenance of active regions (68, 114, 115, 207). Interestingly, it 
has been suggested that H3.3 reduces the association of linker histone H1 to chromatin, 
thus causing a pronounced drop of H1 occupancy at TSSs and at more distant cis-
regulatory sites of active genes (208). We confirmed this theory finding that H1.4 and H1.5 
were increased in H3K9me3 chromatin, while not changed in H3K4me3 domains (Figure 
33A and 33B, respectively) (209). Instead, the SILAC ratio of H1.2 suggested its 
ubiquitous distribution (Figure 33A and 33B), in apparent contradiction with previous 
reports proposing its euchromatic occurrence (210). The accumulation of individual H1 
variants in either active or repressive chromatin suggests their specific contribution to 
establish or maintain the functional status of these regions. Intriguingly, when investigating 
the modification patterns of these variants, we found evidence of at least one novel mono-
methylation on Lysine 90 of H1.2/H1.4, corresponding Lysine 93 of the H1.5 variant 
(Figure 34A and 34B). This preliminary evidence opens the path to the further 
characterization of PTMs of the H1 variants, at present less investigated, due to the lack of 
the adequate variant-specific antibodies.  
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Figure 33. Histone variants enriched in heterochromatin and euchromatin. A) Mass 
spectra of light and heavy SILAC peak pairs from H2AFY, H1.4, H1.5 and H1.2 
demonstrating a specific enrichment of these proteins in the K9me3 ChIP-ed material 
(heavy), over the mock control (light). B) Mass spectra of light and heavy SILAC peak 
pairs from H3.3, H1.4, H1.5 and H1.2 demonstrating a specific enrichment of this variant 
in the K4me3-ChIPed material over the mock control. C) Confirmation of H3.3 enrichment 
in H3K4me3 domains by standard ChIP followed by WB.  
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Figure 34. Novel Lysine 90 or Lysine 93 mono-methylation associate to H1.2/H1.4 and 
H1.5, respectively. A) Zoomed mass spectrum of precursor ions at m/z [637.8879]2+ and 
[645.9029]2+ corresponding to the peptide SLVSKme1GTLVQTK of linker H1.2, H1.4 
and H1.5 species, in light and heavy forms. B) MS/MS spectrum of the peptide H1.2/H1.4 
(86-97) or H1.5 (89-100), from which sequence and methylation was detected. 
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The enrichment of H2A.X in heterochromatin (Figure 35A) was the most 
unexpected finding, given the prevalent literature that focuses only on its Ser139-
phosphorylated form (γ-H2A.X), typically described at the DNA damage foci (211, 212). 
Independent validation of the SILAC-based results by standard ChIP, followed by WB, 
confirmed the accumulation of H2A.X in chromatin regions marked by H3K9me3 (Figure 
35B and 35C).       
 
Figure 35. H2A.X heterochromatic enrichment, measured at the protein level.   A) Mass 
spectra of light and heavy SILAC peak pairs from H2AX in the forward H3K9me3 X-
ChIP: the H/L ratio >1 indicate specific enrichment of this protein. B) Western blot of 
unmodified H2A.X upon ChIP with α-K9me3 and α-K4me3. C) Western blot analysis of 
H3K9me3 and H3K4me3 upon ChIP with α-H2A.X (#1 and #2 indicate two replicates). 
Unmodified H3 is the loading control in both cases.  
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In addition, the measurement of α-satellite repeats and of two H3K4me3 target 
genes (213) by qPCR in α-H2A.X ChIPs indicated that this variant enriches for 
heterochromatic DNA regions but not for active genes (Figure 36A and 36B). Finally, 
H2A.X profiles in ChIP-Seq strongly correlated with H3K9me3, not with H3K4me3 
(Pearson's r: 0.796 and 0.139, respectively) (Figure 36C). 
 
Figure 36. H2A.X heterochromatic enrichment, measured at the gene level. qRT-PCR 
measures the levels of α-satellite repeat regions in H2A.X, H3K9me3 and H3K4me3 
domains IP-ed by N-ChIP (A) and X-ChIP (B), over the mock control. The actively 
transcribed genes PAICS and HSPD1 are used as negative controls. C) ChIP-Seq profile of 
H2A.X, H3K9me3 and H3K4me3 compared to the input, across regions of human 
chromosomes 15 (chr15:15,396,089-38,421,489) and 19 (chr19:6,465,305-41,462,000). 
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In order to reconcile this compelling set of results with the general evidence that 
DNA damage foci marked by γ-H2A.X appear both in silenced and actively transcribed 
chromatin, we formulated a higher local density model, where H2A.X is present all along 
the genome, but its accumulation in repressed regions results either from a higher 
frequency of the variant in heterochromatin than in euchromatin within poly-nucleosomal 
stretches of the same length (the beads-on-string structure), or from a general higher 
density of nucleosomes in heterochromatin, as a consequence of narrower nucleosome 
spacing and/or a more compacted higher-order structure of chromatin (30nm fibers or 
loops) (Figure 37). Accurate measurement of H2A.X enrichment using as input 
nucleosome stretches of distinct and defined lengths, obtained via fine tuned MNAse 
digestion, followed by CsCl purification, may enable to dissect the model (214, 215). 
 
Figure 37. Model of “higher local density” of H2A.X in heterochromatin 
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5.6 Heterochromatic enrichment of the WICH complex, recruited to H2A.X 
An in depth analysis of the H3K9me3-interactome revealed a reproducible 
overrepresentation (top 20%) of the WICH (WSTF-ISWI Chromatin remodeling) complex 
(Figure 38A), an observation that we corroborated by immunofluorescence (Figure 38B). 
WICH consists of two subunits: ISWI, the ATPase subunit common to several remodeling 
complexes that mediate nucleosome positioning (216), and WSTF, encoded by the BAZ1B 
gene. Descriptive studies by immunofluorescence had already observed the accumulation 
of WICH in replicating pericentric heterochromatin (217), however these observation were 
not followed by studies elucidating the mechanism of its recruitment and function in this 
region. 
 
Figure 38. WICH involvement in heterochromatin. A) Mass spectra of light and heavy 
SILAC peak pairs from WSTF and ISWI:  the H/L ratios >1 indicate specific enrichment 
of these proteins. B) WSTF co-localize with HP1β, marker of pericentromeric 
heterochromatin (merge) (1 pixel=0.172 mm; original magnification 60X).  
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The interaction between H2A.X and the WICH complex has been recently proven, 
together with the phosphorylation of Tyrosine 142, in bulk extract, of the same variant by 
WSTF. Phosphorylation of Tyr142 seems to be present in basal conditions, but decreases 
upon double strand breaks (DBSs) (218) (Figure 39A), by EYA-mediated de-
phosphorylation (219). These observations indicate that Tyr142p loss may correlate with  
γ-H2A.X appearance; in line with this idea it has been proposed that the two neighboring 
phosphorylations on Try142 and Ser139 may function as a molecular switch that acts as an 
additional level of regulation of the DNA damage response (DDR) (218). Additionally, we 
discovered an enrichment of this Tyr142p in H3K9me3 domains (Figure 39B), opening the 
possibility that this modification could be associated with heterochromtin.  
Taking together these observations, we thus hypothesize that in basal conditions the 
higher local density of H2A.X may lead to preferential Tyr142 phosphorylation in 
heterochromatin by the accumulating WICH complex and that a delayed DDR, marked by 
γ-H2A.X, may be elicited in this region upon DSBs-induction as a consequence of the 
additional required step of Tyr142 de-phosphorylation (Figure 40).  
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Figure 39. H2A.X Y142p enrichment in H3K9me3-enriched domains. A) Left: WB 
analysis of γ-H2A.X and H2A.X Tyr142p in the Input used for X-ChIP in untreated cells 
and 1 and 4 hours after etoposide treatment, with chat expressing relative quantitation upon 
normalization with loading control H3 (right). B) WB of unmodified H2A.X and H2A.X-
Tyr142p (red arrow), upon ChIP with α-K9me3 and α-K4me3. Unmodified H3 is the 
loading control. Black arrow indicates an unspecific band at lower molecular weight, also 
detected in control. Red upper arrow indicates the specific signal for Tyr142p.  
 
 
                                
 
 
 Figure 40. Model of H2A.X/WICH involvement in DDR, with temporal shift of γ-H2A.X 
appearance upon DSBs between eu- and heterochromatin. 
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ChIP experiments with α-H3K9me3 and α-H3K4me3 (Figure 41A) followed by 
WB to monitor the phosphorylation state of H2A.X confirmed the enrichment of H2A.X 
Tyr142p in heterochromatin versus euchromatin in basal conditions (time point 0 hrs). The 
same assay carried out at two time-points after etoposide treatment suggested that the 
decline of Tyr142p in silenced chromatin slightly precedes the appearance of γ-H2AX 
mark (Figure 41B). To confirm this result we repeated the experiment, extending the 
kinetics of DNA damage until 16h (Figure 41C).  
 
Figure 41. Evaluation of γ-H2A.X and H2A.X Y142p levels upon DNA damage. A) WB 
validation of H3K9me3 and H3K4me3 enrichment in the corresponding ChIPs: an aliquot 
of both input and ChIP samples were loaded on SDS-PAGE, transferred on PVDF and 
probed with α-H3K4me3 (up) α-H3K9me3 (down). B) Upper chart: normalised level of γ-
H2AX and H2AX Y142p for H3K4me3 and H3K9me3 chromatin plotted at basal level 
and after at two time points (1 and 4 hrs) upon etoposide treatment and after X-ChIP 
enrichment, as monitored by WB (bottom panel). The signal for unmodified H3 was used 
as the control to normalize for loading variation. C) WB validation of γ-H2AX and H2AX 
Y142p levels in H3K4me3 and H3K9me3 domains at basal level and after four time points 
(2, 4, 8 and 16 hrs) upon etoposide treatment. 
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6. DISCUSSION 
Chromatin is a highly structured nucleoprotein complex made of histone proteins 
and DNA that controls nearly all DNA-dependent processes. Chromatin plasticity is 
regulated by different associated proteins, post-translational modifications on histones 
(hPTMs) and DNA methylation, which act in a concerted manner to enforce a specific  
“chromatin landscape”, with a regulatory effect on gene expression. Mass spectrometry-
based proteomics has emerged as a powerful analytical method for the analysis of histone 
proteins, their post-translational modifications and variants, as well as their associated 
“writers” and “readers”. ChroP approach represents a novel analytical strategy for the 
proteomic investigation of chromatin at the resolution of a few nucleosomes. ChroP uses a 
modified version of ChIP to isolate native mononuclesomes up to crosslinked 500bp 
oligonucleosomal stretches derived from distinct chromatin domains. Amount, purity and 
quality of the isolated chromatin enable the subsequent mass spectrometric examination of 
the protein component, providing information on histone modification patterns, variants 
and interactors. For the optimization of the method, we focused on two distinct, non 
overlapping chromatin compartments: on the one hand inactive pericentromeric 
heterochromatin and transcriptionally repressed patches of chromatin in actively 
transcribed areas, marked by H3K9me3 and on the other hand active promoters in 
euchromatin, characterized by H3K4me3.  
The analysis of the PTMs enrichment on histone 3 in the H3K9me3 and H3K4me3 
domains confirmed the results recently described using IP of HPLC-purified H3 (28), thus 
verifying the selectivity of the antibodies used in our study. Overall the annotation of the 
H3K9me3 modificome revealed a significant enrichment of known heterochromatic marks, 
with the corresponding depletion of active modifications, whereas an opposite trend was 
observed in the H3K4me3 domains, as expected. The accordance of our results with 
previous studies describing PTMs patterning within the same histone molecule proved the 
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robustness of the strategy, for the following investigation of novel PTMs; more 
importantly, ChroP exhibits a unique strength in revealing PTMs associations also between 
the different core histones within the same mono-nucleosome, enriched at quasi-purity in 
N-ChIP. 
The SILAC-based investigation of the corresponding interactomes by X-ChIP 
confirmed several previously described interactions, thereby validating our method; in 
addition, we identified numerous novel candidate interactors, which have not been 
experimentally described previously. 
The remarkable advantage offered by ChroP consists in the fact that homogeneous 
300-500bp nucleosomal stretches, in which weak protein–protein interactions are stabilized 
by formaldehyde crosslinking, are purified and MS-analyzed: this enables the dissection of 
not only modification “readers”, but also more complex architectural structures, resulting 
from both direct and indirect interactions within intact chromatin domains. For instance, 
the selected H3K9me3 interactome revealed the enrichment of both KDM2A and HP1, 
which previously could be functionally associated only by the intersection of distinct 
independent assays, such as peptide- and GFP- pull downs (147). This gain comes at the 
cost of simplicity of interpretation of the proteomic readout; hence these new composite 
hierarchical protein architectures need to be further dissected (220).   
The two facets of ChroP, N- and X-ChIP, are highly complementary, with the 
possibility of arranging in a unique puzzle the different pieces composing chromatin 
architecture: for instance, the analysis of the H3K9me3 modificome reveals an unexpected 
depletion of H3K36me2/me3, which is explained by the recruitment of KDM2A found by 
the interactomics investigation of the same region. 
Besides recapitulating known interactors, ChroP indicates putative localization in 
distinct chromatin compartments for histone variants and binders not previously described; 
a representative case is offered by the H1 isoforms: the accumulation of individual H1 
variants in either active or repressive chromatin suggests their specific contribution to 
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establish or maintain the functional status of these regions. Intriguingly, when investigating 
the modification patterns of these variants, we found evidence of at least one novel mono-
methylation. This preliminary evidence opens the path to the further characterization of 
PTMs on H1 variants, at present less investigated, due to the lack of the adequate variant-
specific antibodies.  
The presence of the WICH complex and H2A.X in the H3K9me3 chromatome is 
particularly exciting: the “higher local density” of H2A.X in heterochromatin can be 
further developed including the evidence of WICH heterochromatic enrichment, thus 
leading to the hypothesis that H2A.X accumulating in heterochromatin is preferentially 
phosphorylated on Tyr142 by WSTF. Since it has already been proposed that Tyr142p and 
Ser139p function as a molecular switch, we believe that WICH and Tyr142p provide an 
additional regulatory step of DDR in heterochromatin, with an impact on the genomic 
stability in this chromatin region. Some evidence seems to support our model: first,            
γ-H2A.X foci are largely excluded from heterochromatin as compared to active 
euchromatic compartments both in human cells and budding yeast (221-223); second, in 
both human and mouse embryonic fibroblasts, radiation-induced DSBs associated with 
condensed chromatin are repaired more slowly than in euchromatin (224). Despite these 
suggestions, the mechanism underlying the delayed and diminished γ-H2A.X signal in 
heterochromatin remains unclear. According to our model, the delay in γ-H2A.X 
occurrence in heterochromatin may be due to the presence of basal H2A.X Tyr142p that 
must be erased in a regulated manner, preceding γ-H2A.X appearance. In euchromatin,      
γ-H2A.X takes place more quickly, in early DDR, since this intermediate regulatory step is 
not present. Our results represent a very preliminary validation of this model and the first 
step towards the understanding of how the cells may adjust the DNA repair process in 
relation to chromatin compartmentalization (225). In this perspective, the observed 
correlation between aberrant expression of Su(var)3-9, with the consequent alteration of 
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H3K9me3 pattern and HP1 binding and the genomic instability of heterochromatin during 
mammalian development, is highly suggestive (226-228). 
The recruitment of WICH to heterochromatin cannot be explained solely by the 
described binding of WSTF to H2A.X; in fact, although our results suggest a higher local 
density of this variant in heterochromatin, the appearance of the Ser139-phosphorylated 
isoform in both silent and active regions upon DNA damage is not deniable; hence, 
additional mechanisms, including either the binding of the complex to co-clustering 
hPTMs or its interaction with co-enriching proteins, must be postulated. Further studies on 
WSTF interactomes, both soluble and chromatin-bound, will address this open question 
Overall the ChroP approach described here offers the possibility to dissect the 
synergism of hPTMs, variants and non-histonic interactors at functionally distinct 
chromatin domains, with a resolution of mono- to oligo-nuclesomes. The approach is 
relatively easy to setup and to be implemented in the epigenetics groups, given the limited 
changes made to the conventional N- and X- ChIP protocols, used for ChIP-Seq studies. 
Hence, for the relatively straightforward optimization, we predict that ChroP will be 
amenable to numerous applications in more functional studies, for instance to study the 
dynamic changes of the modificome and intractome of specific chromatin regions upon 
various perturbations, such as global transcriptional activation, differentiation, depletion of 
distinct chromatin components, or treatment with epigenetic drugs.  Therefore our ChroP 
strategy emerges as an additional and valuable tool in the arsenal of analytical strategies 
available to study chromatin composition and dynamics in a system-wide fashion. 
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7. CONCLUSIONS AND PRESPECTIVES 
During these years I have established a novel proteomics approach combining two 
common and complementary methods, typically employed separately by the researchers to 
investigate the epigenetic components of chromatin: chromatin immunoprecipitation and 
Mass Spectrometry analysis. On the one hand MS served to characterize the PTMs co-
associated to enriched sub-domains and on the other hand to annotate the corresponding 
“chromatin interactome”, representing all the non-histonic proteins specifically interacting 
within the same chromatin domains. The results that I have obtained characterizing the 
composition of heterochromatin and euchromatin support the vision that chromatin is a 
composite puzzle, made of many pieces, which coordinately act to regulate the functional 
state of the underlying DNA. Due to this complexity, novel approaches such as ChroP, 
based on the combination of different analytical techniques, may represent the solution to 
better understand how the structural and functional interactions among different epigenetic 
components of chromatin enforce specific functional transition on the genome. 
Although ChroP proved to be a very robust approach and highly complementary to 
more conventional strategies to analyze chromatin, I have envisaged two minor limitations 
of the project: the first is more methodological, and the second regards the application of 
the method to functional studies.  
Concerning the methodological aspect, although N-ChroP followed by “Bottom 
Up” MS analysis enables to characterize the modifications associated with distinct 
chromatin domains, the detection of the combinatorial aspect of the histone code has been 
only partially addressed in my study. As discussed in the introduction (see paragraph 
2.2.2), the “Bottom Up” analysis with CID fragmentation offers only a partial view of the 
complex cross-talks among different hPTMs; therefore I would be interested in analyzing 
the nucleosomes purified by N-ChroP with a combination of “Bottom Up” and “Middle 
and Top Down” approaches, to effectively achieve a more comprehensive view on the 
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hPTMs stochiometry and abundances at specific regions and to finally “crack” the code. In 
fact, “Middle and Top Down” methods are employed to study longer peptides up to intact 
proteins, respectively. The longer peptides can be generated either spontaneously by 
missed cleavage of trypsin or by using different proteases, such as Asp-N and Glu-C. The 
fragmentation technique employed to analyze those longer and highly charged peptides is 
electron transfer dissociation (ETD). Recently, ETD was also employed to improve the 
detection of Arginine methylation; hence I plan to focus on histone Arginine methylation, a 
modification that is less characterized than Lysine methylation, but instead equally 
biological relevant. 
The second limitation of my study regards the fact that I restricted the use of ChroP 
for the analysis to chromatin domains of HeLa cells, which makes my study an optimal 
proof of principle but not particularly relevant in a functional perspective. In fact HeLa 
were a useful cell line for the set up of the method because they are easy to culture and to 
scale up; furthermore the hPTMs patterns are largely characterized in bulk. However, they 
are not representative of specific cell type or specific function. In this respect, I think that 
applying this approach to a different model system and in a dynamic manner will be useful 
to profile the epigenetic changes during functional transitions, such as a global wave of 
transcriptional activation or a change from healthy condition to disease. In the follow up of 
my project, we started to explore distinct chromatin domains using macrophages as a 
model system, upon LPS stimulation. Moreover, we intend to use ChroP for a more in-
depth dissection of euchromatin, investigating cis-regulatory regions characterized by 
H3K4me1 (enhancers) and H3K4me3 (transcription start sites, TSSs). Taking advantage of 
these two modifications as bait, we started to use N-ChIP and X-ChIP to enrich these 
regions and to use MS to analyse hPTMs, variants and protein complexes, before and after 
LPS stimulation. As such we will be able to quantitatively profile how they dynamically 
change in a coordinated manner, upon inflammation. 
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9. APPENDIX 
APPENDIX I. MS/MS spectra of H3 (3-8) peptide, containing the Lysine 4. 
Fragmentation spectra were used for the site-specific assignment of modifications within 
the peptides; MASCOT search, with the most intense ions identified in the MSMS spectra 
and relative calculated score: experimental spectra are displayed. 
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APPENDIX II. MS/MS spectra of H3 (9-17) peptide, containing the Lysine 9 and 14. 
Fragmentation spectra were used for the site-specific assignment of modifications within 
the peptides; MASCOT search, with the most intense ions identified in the MSMS spectra 
and relative calculated score: experimental spectra are displayed. 
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APPENDIX III. Informations contained in the interactome tables. 
Gene Names: Name(s) of the gene(s) associated to the protein(s). 
Uniprot: UniProt (http://www.uniprot.org) ID(s) of the protein(s).  
Peptides: The total number of peptide sequences associated with the protein group (i.e. for 
all the proteins in the group) (For and Rev, indicate Forward and Reverse experiments, 
respectively). 
Unique Peptides: The total number of unique peptides associated with the protein group 
(e.g. these peptides are not shared with another protein group). (For and Rev, indicate 
Forward and Reverse experiments, respectively). 
Sequence Coverage [%]: Percentage of the sequence that is covered by the identified 
peptides of the best protein sequence contained within the group. 
Mol. Weight [kDa]: Molecular weight of the best protein sequence contained within the 
protein group. 
Sequence Length: The total length of the best protein sequence contained within the group. 
Ratio H/L For: Ratio H/L Normalized divided to the standard deviation in the Forward 
experiment.  
Ratio H/L Count For: Number of redundant peptides used for quantitation in Forward 
experiment. 
Ratio H/L Rev: Ratio H/L Normalized divided to the standard deviation in the Reverse 
experiment.  
Ratio H/L Count Rev: Number of redundant peptides used for quantitation in the Reverse 
experiment. 
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APPENDIX IV. Proteins identified and quantified with a least two peptides, one of 
which unique, in the H3K9me3 interactome. Protein Group output from MaxQuant 
software, representing the Top40% of proteins binders. 
 
 
Gene Names Uniprot Peptides For 
Peptides 
Rev 
Unique 
Pep. For 
Unique 
Pep. Rev 
Sequence Coverage     
[%] 
Mol. 
Weight     
[kDa] 
Sequence Length Ratio H/L For 
Ratio H/L 
Count For 
Ratio 
H/L Rev 
Ratio H/L 
Count Rev 
CBX1 B5MD17 3 2 2 1 18.5 21.915 189 3.2932 3 0.0996 1 
HIST2H3PS2 Q5TEC6 6 5 1 1 27.2 15.43 136 4.4974 13 0.1133 6 
BAF O75531 3 2 3 2 56.2 10.058 89 4.3362 4 0.1347 2 
H2AFA P04908 6 4 1 1 57.7 14.135 130 7.8716 6 0.1578 1 
SFRS10 Q59GA1 6 5 6 5 20.4 33.571 289 3.9058 10 0.1863 16 
DEK P35659 12 9 12 9 30.1 42.674 375 3.0638 29 0.2130 26 
SP140L Q9H930-1 2 2 1 1 3.4 67.005 580 2.5578 2 0.2315 1 
SFRS3 P84103 6 5 5 4 38.4 19.329 164 2.7555 9 0.2460 10 
NP220 Q14966-1 21 13 21 13 12.9 220.62 1978 4.6609 22 0.2464 16 
SFRS6 Q13247-1 8 6 7 5 24.4 39.586 344 3.6453 12 0.2479 16 
ASF Q07955-1 11 10 10 10 47.6 27.744 248 4.0771 29 0.2491 35 
TRA2A Q13595-1 2 2 2 2 8.2 32.688 282 5.1072 3 0.2492 3 
HIST2H2AB Q8IUE6 4 2 1 1 40 13.995 130 3.3613 3 0.2505 1 
SFRS7 Q16629-1 7 5 6 4 29.4 27.366 238 3.0631 18 0.2587 16 
SAFB A0AV56 17 16 8 6 22.4 102.85 917 5.4024 16 0.2606 11 
HNRNPU Q00839-1 33 30 33 30 41.3 90.583 825 3.6163 125 0.2642 122 
SFRS2 Q01130 7 6 7 6 37.1 25.476 221 3.8919 10 0.2721 19 
CBX3 Q13185 7 5 5 4 36.6 20.811 183 3.5583 18 0.2739 15 
KIAA0138 Q14151 25 26 16 16 31 107.47 953 5.8520 42 0.2744 41 
YLPM1 B4DMQ9 10 4 10 4 5.3 241.64 2146 4.5553 9 0.2813 4 
RNPU1Z P08621-1 9 10 9 10 29.5 51.556 437 3.2193 10 0.2819 19 
 
Q1AHP8 4 2 1 1 17.6 28.019 245 3.5338 5 0.2840 1 
RBM12B Q8IXT5 13 11 13 11 18.5 118.1 1001 5.3077 26 0.2843 11 
H4/A P62805 11 10 11 10 54.4 11.367 103 3.4679 212 0.2869 122 
H1F2 P16403 18 13 5 3 46 21.364 213 3.0975 108 0.2935 94 
H2AFY O75367-1 15 16 15 16 51.9 39.617 372 3.2085 68 0.2955 37 
RBAP48 Q09028 5 4 1 1 12 47.655 425 4.3997 1 0.2985 1 
TOP2 P11388-4 34 34 25 25 22 182.68 1612 2.4628 71 0.3030 77 
AHCTF1 Q8WYP5-2 12 12 12 12 7.2 256.25 2304 2.4872 18 0.3033 8 
ATAD2 Q6PL18-1 16 14 16 14 17.9 158.55 1390 2.4075 26 0.3039 17 
HRS Q13243-1 5 3 4 2 19.9 31.263 272 3.3101 6 0.3051 2 
H2BFD B4DR52 13 12 2 2 50 18.041 166 2.3233 27 0.3057 20 
RIF1 C9JI70 2 4 2 4 2.9 274.48 2472 2.1838 3 0.3057 4 
HNRNPA1 P09651-1 18 18 12 11 51.9 38.845 372 3.7049 123 0.3148 66 
INCENP Q9NQS7-1 8 4 8 4 9 105.43 918 2.5677 9 0.3149 3 
SFRS9 Q13242 8 6 7 6 35.3 25.542 221 4.5666 12 0.3209 4 
MET Q9NWH9 15 14 15 14 17.2 117.15 1034 4.5699 28 0.3222 13 
BRE1A Q5VTR2 3 3 2 2 5.9 113.98 977 4.2904 2 0.3236 2 
HNRPG P38159 16 14 5 5 39.1 42.331 391 4.7885 50 0.3251 41 
BRE1B O75150-1 2 2 1 1 2.5 113.68 1001 2.5983 1 0.3254 1 
FUSIP1 O75494-1 5 4 5 4 23.3 31.3 262 5.1612 7 0.3338 8 
H2BFH P23527 13 12 2 2 65.9 13.906 126 2.4963 158 0.3350 92 
ADNP Q9H2P0 2 2 2 2 2.6 123.56 1102 2.5284 3 0.3371 2 
CBX5 P45973 9 8 8 8 53.4 22.225 191 2.3396 17 0.3393 11 
FTP3 P55795 6 5 1 1 17.1 49.263 449 6.2432 1 0.3444 1 
BTF3 P20290-1 4 3 4 3 20.9 22.168 206 2.9262 5 0.3457 3 
H1F5 P16401 12 10 6 7 34.5 22.58 226 2.6446 15 0.3503 16 
WIZ O95785-1 6 5 6 5 7.7 178.67 1651 4.4522 5 0.3515 3 
CGI-55 Q8NC51-1 5 6 5 6 17.4 44.965 408 6.5009 7 0.3517 9 
HNRPDL O14979-1 4 5 3 4 14.5 46.437 420 3.0269 8 0.3520 7 
HNRNPA3 P51991-1 6 8 5 6 31.2 39.594 378 3.6357 21 0.3568 14 
H2AFZ P0C0S5 4 4 2 2 22.1 18.414 181 3.2308 11 0.3572 7 
H1F4 P10412 14 11 1 1 42.5 21.865 219 2.6054 13 0.3583 4 
BAZ1B Q9UIG0-1 36 31 36 31 29.9 170.9 1483 2.5349 56 0.3594 39 
ZFR B5MEH6 8 10 8 10 15.4 115.15 1056 2.7555 9 0.3645 9 
C3orf63 Q9UK61-1 2 11 2 11 7 189.03 1670 2.4775 2 0.3671 8 
PHIP Q8WWQ0 9 6 9 6 6.2 206.64 1821 2.7464 10 0.3688 7 
RCC1 Q16269 9 8 9 8 27.9 48.145 452 3.0074 24 0.3716 12 
U2AF2 P26368-1 3 3 3 3 15.8 53.5 475 3.1405 3 0.3721 4 
HCC1 Q14498-1 6 6 6 6 23.2 59.379 530 2.2574 12 0.3726 17 
HP1BP3 Q5SSJ5-1 19 15 19 15 30.9 61.206 553 3.2489 44 0.3764 29 
KIAA0650 A6NHR9-1 36 29 36 29 20.7 226.37 2005 2.2309 53 0.3804 31 
CENPV Q7Z7K6-1 5 5 1 1 29.1 29.946 275 2.6043 8 0.3856 7 
ORC1 Q13415 2 3 2 3 4.4 97.349 861 3.6960 2 0.3901 3 
TOP2B Q02880-1 18 18 9 9 14.1 183.26 1626 3.2180 11 0.3924 8 
HDGF P51858 7 7 7 7 34.6 26.788 240 3.0906 14 0.3961 9 
TRIP12 Q14CA3 8 8 8 8 6.3 225.52 2040 2.4182 7 0.4025 8 
NONO Q15233 21 20 18 17 46.5 54.231 471 3.6094 69 0.4036 41 
HMG1 P09429 9 7 6 4 40 24.893 215 2.8833 21 0.4052 8 
GEMIN5 Q8TEQ6 2 2 2 2 1.1 168.56 1508 3.0161 1 0.4074 1 
hCG_15646 B1AMT5 10 11 10 11 10.4 145.75 1268 2.5166 11 0.4083 9 
 
C9JMX5 5 4 1 1 24.6 27.378 240 2.7292 5 0.4105 6 
ITM1 P46977 2 4 2 4 5.8 80.529 705 2.2627 3 0.4139 5 
CHD4 Q14839-2 14 14 14 14 8.7 220.83 1940 2.1331 19 0.4143 19 
CREAP1 O95232-1 4 2 4 2 12 51.466 432 2.2664 4 0.4156 3 
U2AF1 Q01081 4 5 4 5 17.9 27.872 240 2.5454 8 0.4166 9 
ANP32B Q92688-1 6 2 4 2 28.7 28.787 251 2.4901 6 0.4173 2 
PC4 P53999 3 2 3 2 26 14.395 127 2.7610 7 0.4185 6 
SMT3B P61956 2 2 1 1 23.2 10.871 95 2.6900 12 0.4187 13 
KIAA0067 Q15047-1 7 8 7 8 8 143.16 1291 8.4735 4 0.4235 1 
USP31 Q86UV5-1 3 2 3 2 5.3 120.52 1047 3.0686 2 0.4255 1 
PBSCG A8MWD9 5 3 5 3 36.8 8.544 76 2.4652 6 0.4290 4 
CXXC8 Q9Y2K7-1 8 7 8 7 8.8 132.79 1162 2.1987 17 0.4304 7 
AUF1 Q14103-1 9 12 8 11 32.1 38.434 355 3.2811 29 0.4307 32 
RPL23A P62750 11 11 11 11 43.6 17.695 156 2.7402 29 0.4362 36 
SMARCA5 O60264 39 36 39 36 36.7 121.9 1052 2.4841 60 0.4377 45 
UHRF1 A8K024 15 12 15 12 29.3 91.099 806 2.2292 21 0.4393 13 
LMN2 Q03252 25 20 19 15 42.3 69.948 620 2.2876 36 0.4394 16 
CDC46 P33992 25 22 25 22 45.1 82.285 734 2.2345 50 0.4400 31 
HNRNPH3 P31942-1 6 6 5 5 26.3 36.926 346 3.2615 11 0.4445 9 
UBA52 P62987 9 8 9 8 53.9 14.728 128 2.8335 97 0.4455 89 
CENPV Q7Z7K6-3 5 5 1 1 28.3 29.73 272 2.3588 1 0.4473 1 
AIM P26358-1 35 28 35 28 26.3 189.56 1678 2.2571 40 0.4533 29 
KIAA1637 Q9HCD5 3 3 3 3 7.8 65.536 579 6.9046 2 0.4570 2 
ARGLU1 Q9NWB6-1 3 2 3 2 15 33.216 273 2.5414 4 0.4611 4 
KIAA0461 Q7Z3K3-1 2 3 2 3 3.3 155.34 1410 3.0215 2 0.4618 2 
HNRNPF P52597 8 7 6 5 25.3 45.671 415 2.9972 14 0.4620 11 
HNRNPC P07910-2 13 12 13 12 44.4 32.337 293 2.5864 86 0.4624 50 
HNRNPA2B1 P22626-1 21 21 20 20 63.5 37.429 353 3.4488 114 0.4657 93 
CDCA8 Q53HL2 7 2 7 2 30.4 31.323 280 2.3632 8 0.4659 2 
SET Q01105-1 3 4 3 4 22.8 33.488 290 2.4842 6 0.4661 5 
hCG_22498 B2R7C5 31 29 31 29 44.2 95.907 853 2.2148 66 0.4675 36 
LMN1 P02545-1 50 49 3 3 64.8 74.139 664 2.2876 345 0.4685 236 
ZNF326 Q5BKZ1-1 6 4 6 4 12 65.653 582 2.6638 8 0.4720 6 
FANCI Q9NVI1-3 8 7 8 7 11.3 149.32 1328 2.6239 6 0.4730 6 
KIAA1291 Q9HAV4-1 2 2 2 2 1.7 136.31 1204 2.4632 2 0.4730 2 
HNRNPL P14866 15 14 14 13 29.4 64.132 589 3.5264 43 0.4735 35 
HNRPCL2 Q9UKM9-1 11 11 11 11 29.3 32.55 307 2.7391 17 0.4741 15 
ILF2 Q12905 10 9 10 9 33.1 43.062 390 2.4864 19 0.4741 15 
KHDRBS1 Q07666-1 6 5 6 5 14 48.227 443 3.9629 11 0.4752 10 
CGI-59 Q9Y383-1 7 5 3 1 16.8 54.223 458 2.5075 12 0.4761 14 
LMN2 P20700 38 35 32 30 59.7 66.408 586 2.3030 114 0.4785 79 
RBM14 Q96PK6-1 15 14 13 11 27.5 69.491 669 2.8425 39 0.4792 22 
DDX46 Q7L014 19 13 19 13 23 117.46 1032 2.1652 22 0.4807 24 
H1F0 P07305 4 4 4 4 20.6 20.863 194 3.0118 6 0.4814 4 
TARDBP Q13148 4 4 4 4 12.3 44.991 416 2.5003 6 0.4814 5 
KIAA0648 Q29RF7-1 10 14 9 12 15.8 150.83 1337 2.2261 11 0.4861 14 
CG1 Q86UP2-1 9 20 9 20 18.3 156.27 1357 2.5712 11 0.4894 24 
SPNR Q96SI9-1 7 8 4 5 13.7 73.652 672 3.5726 4 0.4899 5 
HNRNPA0 Q13151 9 7 9 7 39.3 30.84 305 3.1982 20 0.4906 17 
ANP32A P39687 7 3 3 2 26.5 28.585 249 2.5897 8 0.4942 3 
PSF P23246-1 22 24 20 22 38.3 76.149 707 3.1636 74 0.4950 68 
H1FX Q92522 10 9 10 9 41.3 22.487 213 2.9653 29 0.4958 15 
MLN70 P31949 5 4 5 4 52.4 11.74 105 3.0840 8 0.4966 5 
DDX5 P17844 29 28 22 21 41.5 69.147 614 2.6988 73 0.4968 54 
FUS P35637-1 6 6 4 4 11.2 53.376 528 3.6193 18 0.4997 18 
DNAJC9 Q8WXX5 9 4 9 4 28.8 29.909 260 3.3611 10 0.5003 3 
CPSF1 Q10570 6 6 6 6 6.8 160.88 1443 3.1944 7 0.5028 5 
DBP2 O60231 4 2 4 2 4.3 119.26 1041 2.6248 4 0.5038 2 
RBAP46 Q16576 6 4 2 1 15.3 47.82 425 4.5516 7 0.5084 5 
KIAA0144 Q14157-2 3 6 3 6 6.5 114.53 1087 2.6252 3 0.5105 8 
HNRNPK P61978-3 19 18 19 18 53 48.562 440 3.2319 77 0.5105 79 
HNRNPR O43390-1 20 20 1 1 37.9 70.942 633 3.0983 66 0.5136 62 
MATR3 A8MXP9 21 21 21 21 33.4 99.966 895 2.6669 55 0.5152 70 
HELLS Q9NRZ9-1 14 7 14 7 18.6 97.073 838 2.7513 16 0.5214 5 
ABBP1 Q99729-2 10 9 10 9 29.8 35.967 332 2.9267 28 0.5251 23 
SNRPE P62304 4 2 4 2 65.2 10.803 92 3.0900 4 0.5256 1 
BAF170 Q8TAQ2-1 2 5 1 2 5.4 132.88 1214 3.1546 2 0.5285 6 
CTDSPL2 Q05D32-1 3 3 3 3 5.8 52.998 466 3.2513 3 0.5334 2 
DXS423E Q14683 33 35 33 35 34 143.23 1233 2.1855 56 0.5385 41 
HNRNPH1 P31943 11 9 5 4 35.2 51.229 472 2.3682 47 0.5432 28 
CFIM25 O43809 9 8 9 8 39.2 26.227 227 2.8758 15 0.5444 9 
APE P27695 9 8 9 8 46.2 35.554 318 3.0723 16 0.5484 10 
MCM6 Q14566 30 26 30 26 43 92.888 821 2.1212 49 0.5492 31 
HNRNPUL2 Q1KMD3 13 17 13 17 26.4 85.104 747 3.0236 20 0.5498 20 
RPS11 P62280 11 11 5 4 57.6 18.431 158 2.2376 26 0.5533 25 
FUBP2 Q92945-1 16 14 13 12 31.4 73.114 711 2.7493 17 0.5550 15 
RPS24 P62847-1 4 3 4 3 16.3 32.43 289 2.4187 5 0.5578 6 
KIF4 O95239-1 3 2 3 2 2.4 139.88 1232 3.0106 3 0.5589 1 
EIF4B P23588 3 2 3 2 6.5 69.725 616 2.4866 4 0.5598 3 
HMG2 P26583 8 6 6 4 33 24.033 209 2.8399 17 0.5607 4 
CSTF3 Q12996 5 4 5 4 12.7 82.921 717 2.7508 5 0.5611 3 
FUBP1 Q96AE4-1 21 17 17 15 43.9 67.689 645 2.7642 38 0.5618 31 
CDC47 P33993-1 25 18 25 18 47.8 81.307 719 2.1318 52 0.5618 25 
RPS7 P62081 12 10 12 10 50 22.127 194 2.4593 25 0.5632 21 
CDC21 P33991 24 22 24 22 36.7 96.557 863 2.4214 63 0.5673 27 
hCG_20560 Q9BUQ0 13 9 13 9 35 59.632 557 2.7678 39 0.5734 27 
KIAA1470 Q9P258 14 12 14 12 34.7 56.084 522 2.9194 30 0.5746 26 
E1BAP5 Q9BUJ2-1 5 6 5 6 10.6 95.737 856 2.5961 9 0.5831 6 
WDR76 Q9H967 8 9 8 9 14.7 69.752 626 2.4178 12 0.5854 8 
DDX17 Q59F66 23 21 16 14 35.2 80.457 731 2.6552 43 0.5856 36 
RPL38 P63173 6 4 6 4 52.9 8.2178 70 3.6526 9 0.5868 6 
RPL6 B2R4K7 13 14 13 14 49.5 32.872 289 2.4866 27 0.5887 37 
DDX38 Q92620 4 3 4 3 5.5 140.5 1227 2.2700 3 0.5900 3 
LEMD3 Q9Y2U8 6 4 6 4 9.7 99.996 911 2.1906 6 0.5947 4 
ERH P84090 3 3 3 3 37.5 12.259 104 2.2329 3 0.5985 3 
VRK1 Q99986 2 2 2 2 11.6 45.476 396 5.0153 2 0.6002 2 
SRP9 P49458 4 4 4 4 43 10.112 86 2.5566 5 0.6041 5 
RPL17 P18621 9 9 9 9 51.6 21.397 184 2.4736 24 0.6090 27 
HAUSP Q93009 14 12 14 12 16.2 128.3 1102 2.1417 17 0.6108 13 
EEF1D P29692-1 9 8 1 1 55.2 31.121 281 3.1740 1 0.6108 4 
DRBF Q12906-4 21 19 18 16 26.8 95.807 898 2.4906 62 0.6151 36 
SRP14 P37108 7 5 7 5 44.1 14.57 136 2.8571 9 0.6166 6 
HSD48 Q13765 4 4 4 4 5.9 94.68 925 2.1525 10 0.6185 13 
RBP56 Q92804-1 3 4 1 2 8.3 61.829 592 3.0270 1 0.6228 2 
KIAA1401 Q2NL82 13 11 13 11 21 91.809 804 2.2232 18 0.6253 12 
C6orf150 Q8N884-1 7 6 7 6 18.4 58.814 522 2.8504 9 0.6308 4 
HNRNPM P52272-1 31 26 31 26 50.1 77.515 730 2.6294 87 0.6336 73 
WBSCR22 C9K060 3 2 3 2 16.4 33.845 298 2.5071 3 0.6337 3 
AAG P29372-1 10 4 10 4 41.3 32.868 298 2.9860 10 0.6394 5 
ELAVL1 B4DVB8 12 9 12 9 36.5 38.996 353 2.9276 17 0.6398 17 
EMC19 P63208-1 3 3 3 3 20.2 18.658 163 2.1302 3 0.6436 3 
ARS2 Q9BXP5-1 6 4 6 4 10.2 100.67 876 2.2638 6 0.6503 6 
UHX1 P51784 2 2 1 2 2.8 109.82 963 2.8429 2 0.6527 2 
FEN1 P39748 9 9 9 9 31.8 42.592 380 2.3008 13 0.6546 8 
BAM Q9UQE7 22 25 22 25 25.6 141.54 1217 2.1525 34 0.6549 26 
DBC1 Q8N163-1 11 12 11 12 20.3 102.9 923 2.1721 13 0.6554 18 
RPL1 P36578 16 17 16 17 38.9 47.697 427 2.4236 37 0.6595 33 
FLYWCH1 Q4VC44-3 7 5 1 1 17.1 85.152 765 2.1598 9 0.6618 2 
HCA90 Q96RR5 3 2 3 2 5.5 89.392 783 2.8632 4 0.6626 2 
LBR Q14739 2 2 2 2 3.1 70.702 615 2.3942 3 0.6666 7 
EIF2G P41091 6 5 6 5 12.9 51.109 472 4.6697 8 0.6686 6 
LAP2 P42167-1 9 10 4 4 29.3 50.67 454 6.3721 5 0.6727 4 
DFS70 O75475-1 5 4 5 4 13.2 60.103 530 2.6389 6 0.6767 6 
TKT B4DE31 25 23 25 23 45.3 68.741 631 2.2096 72 0.6891 46 
CDYL Q9Y232-1 2 2 2 2 4.2 66.481 598 2.3043 2 0.6921 1 
hCG_2016483 B3KUY2 3 3 3 3 31.5 19.448 165 2.2226 4 0.6949 3 
RPL7A P62424 16 15 16 15 45.5 29.995 266 2.3846 31 0.6972 33 
POLR2B P30876 4 4 4 4 6.5 133.9 1174 2.4870 4 0.6980 4 
AEG1 Q86UE4 3 5 3 5 13.9 63.836 582 2.2140 3 0.6980 6 
CFIM68 Q16630-2 3 4 3 4 8.8 63.47 588 2.6267 5 0.6988 4 
DAD1 P61803 3 3 3 3 26.5 12.497 113 2.2949 4 0.6991 3 
RPL12 P30050-1 8 7 8 7 68.5 17.818 165 2.3098 10 0.6999 11 
EEF1G P26641 12 12 12 12 37.8 50.118 437 2.8496 30 0.7096 20 
NSUN2 Q08J23 18 13 18 13 30.2 86.47 767 2.1227 26 0.7124 15 
GTF3C4 Q9UKN8 4 2 4 2 4.5 91.981 822 2.4275 4 0.7139 2 
RPS10 P46783 6 7 6 7 37.6 18.898 165 2.2386 12 0.7148 13 
PA2G4 Q05D08 9 9 9 9 33.7 45.151 406 2.5044 11 0.7182 15 
TIAL1 A8K4L9 2 3 1 1 11 43.448 392 2.9172 3 0.7206 4 
KIAA0664 O75153 6 13 6 13 11.1 146.67 1309 2.4806 6 0.7237 12 
CACY P06703 2 2 2 2 16.7 10.18 90 2.6325 3 0.7265 2 
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APPENDIX V. Proteins identified and quantified with a least two peptides, one of which 
unique, in the H3K4me3 interactome. Protein Group output from MaxQuant software, 
representing the Top40% of proteins binders. 
 
 
Gene Names Uniprot Peptides         For 
Peptides           
Rev 
Unique 
Pep.                 
For 
Unique 
Pep.                   
Rev 
Sequence Coverage             
[%] 
Mol. 
Weight              
[kDa] 
Sequence Length 
Ratio 
H/L               
For 
Ratio H/L 
Count              
For 
Ratio 
H/L                   
Rev 
Ratio H/L 
Count               
Rev 
MKI67 P46013-1 43 52 43 52 23 358.69 3256 1.7868 83 0.4569 103 
H4/A P62805 10 11 10 11 53.4 11.367 103 2.1203 91 0.4112 99 
ADPRT P09874 33 32 33 32 38.3 113.08 1014 1.7925 55 0.4903 78 
H3F2 Q71DI3 8 8 1 1 60.3 15.388 136 2.3171 79 0.2245 71 
UBA52 P62987 9 9 9 9 53.9 14.728 128 1.8880 67 0.5509 69 
H1F2 P16403 9 13 3 5 41.8 21.364 213 1.9563 71 0.2012 66 
DDX21 Q9NR30-1 29 30 27 28 44.7 87.343 783 1.7614 53 0.5866 60 
TOP2 P11388-4 39 35 28 23 25 182.68 1612 1.9910 63 0.4972 53 
BAP135 P78347-1 21 26 21 26 28.4 112.42 998 1.7741 37 0.4932 38 
H2AFY O75367-1 13 16 13 16 51.9 39.617 372 1.7913 27 0.3936 32 
SMARCA5 O60264 20 26 20 26 26 121.9 1052 1.9681 30 0.5696 32 
CHD4 Q14839-2 25 29 25 29 14.9 220.83 1940 2.0812 38 0.4547 30 
KIAA1470 Q9P258 7 13 7 13 34.7 56.084 522 2.4348 12 0.4757 25 
OK/SW-cl.32 P39023 12 12 12 12 24.8 46.108 403 1.8436 22 0.4282 24 
NCL P19338 16 15 16 15 28.5 76.613 710 2.1770 21 0.6351 20 
CATX11 O76021 15 16 15 16 30 54.972 490 2.0376 18 0.5078 20 
POLR2B P30876 18 17 18 17 25.1 133.9 1174 4.3296 19 0.3597 20 
SIN3A Q96ST3 20 18 20 18 19.6 145.17 1273 4.9947 27 0.3457 19 
H1FX Q92522 4 5 4 5 26.3 22.487 213 1.7493 15 0.5633 18 
H2BFD B4DR52 7 9 2 2 42.8 18.041 166 2.3429 22 0.2335 18 
RPL7 A8MVV7 10 11 10 11 46.3 32.275 272 1.7305 16 0.5883 17 
HMGB1 Q5T7C6 6 8 5 7 30.6 25.814 216 4.5691 11 0.1385 16 
IFI16 Q16666-1 14 13 14 13 21.5 88.255 785 1.8129 16 0.5098 16 
FACT140 Q9Y5B9 11 14 11 14 16.5 119.91 1047 2.7876 16 0.6320 16 
DEK P35659 8 8 8 8 24.5 42.674 375 2.4557 13 0.4984 15 
hCG_1744585 B5MDF5 8 8 8 8 28.4 26.409 236 1.8618 17 0.6449 15 
CCG2 P62701 12 10 12 10 42.6 29.597 263 1.7695 21 0.5316 15 
DDB1 Q16531 9 13 9 13 12 126.97 1140 2.0345 10 0.6181 15 
POLR2 P24928 20 19 20 19 12.8 217.17 1970 3.4119 27 0.5150 15 
HCFC1 A6NEM2 13 14 12 13 9.3 213.47 2080 4.0966 17 0.2985 14 
HRX2 Q9UMN6-1 25 34 23 30 17.4 293.51 2715 9.1265 7 0.6063 14 
SPT5 O00267-1 9 14 9 14 17.8 121 1087 4.2804 7 0.3172 13 
BRIX Q8TDN6 7 8 7 8 25.2 41.401 353 1.8298 11 0.5072 12 
DDX48 P38919 11 10 9 8 29.4 46.871 411 1.9080 8 0.4565 12 
FACT80 Q08945 11 11 11 11 20.5 81.074 709 2.9439 11 0.4560 12 
FBL P22087 7 8 6 7 29 33.784 321 2.6688 10 0.1622 11 
KIAA0648 Q29RF7-1 11 13 9 11 11.3 150.83 1337 1.7513 12 0.5711 11 
H2AFZ P0C0S5 4 4 2 2 22.1 18.414 181 3.4120 10 0.4642 10 
OK/SW-cl.103 P32969 5 6 5 6 32.3 21.863 192 1.7475 7 0.6451 10 
PA2G4 Q05D08 4 7 4 7 20.2 45.151 406 1.9197 4 0.6417 10 
HDGF P51858 6 7 5 6 32.5 26.788 240 2.2109 7 0.3490 10 
HNRNPA3 P51991-1 5 6 5 6 21.2 39.594 378 1.9481 6 0.3712 9 
HIST2H3PS2 Q5TEC6 6 6 1 1 36.8 15.43 136 5.3761 9 0.0939 9 
EBNA1BP2 Q99848 7 6 7 6 19.9 40.684 361 2.4007 9 0.1223 9 
ILF2 Q12905 6 7 6 7 21.5 43.062 390 1.8692 6 0.5533 9 
DDX27 Q96GQ7 9 10 9 10 15.2 89.834 796 1.8093 10 0.6135 9 
HNRNPA0 Q13151 2 2 2 2 5.2 30.84 305 1.7985 7 0.4188 8 
RPL38 P63173 5 5 5 5 50 8.2178 70 2.2918 7 0.1413 8 
NPM P06748-1 3 6 3 6 35.7 32.575 294 1.7325 6 0.4265 8 
RPL6 B2R4K7 8 8 8 8 31.5 32.872 289 2.0003 8 0.2603 8 
APE P27695 3 7 3 7 30.2 35.554 318 2.5524 3 0.3147 7 
GTBP P52701-1 4 7 4 7 5.8 152.78 1360 1.8848 5 0.6428 7 
RECQ1 P46063 7 7 7 7 15.4 73.457 649 2.6266 9 0.4508 7 
UBF P17480-1 5 8 5 8 11.4 89.405 764 2.5658 5 0.5814 7 
VCP P55072 11 9 11 9 23.3 89.321 806 5.2788 7 0.3455 7 
SMT3B P61956 2 2 2 2 23.2 10.871 95 2.1903 8 0.5237 6 
DB1 Q14119 3 3 2 2 5.6 56.931 521 5.0997 5 0.1494 6 
RPL13A P40429 3 4 3 4 17.7 23.577 203 2.0527 4 0.5182 6 
EEF1G P26641 3 5 3 5 16 50.118 437 1.8519 3 0.2553 6 
CDABP0061 Q9Y5J1 5 5 5 5 14.3 64.063 573 1.7505 4 0.5171 6 
BAF170 Q8TAQ2-1 3 6 1 4 6 132.88 1214 1.8881 4 0.5652 6 
HR21 O60216 4 7 4 7 13.5 71.689 631 2.2118 4 0.5660 6 
KIAA0162 Q7KZ85-1 10 10 10 10 11.7 199.07 1726 3.0494 10 0.3732 6 
SRP14 P37108 4 4 4 4 55.1 14.57 136 1.8638 6 0.1708 5 
CYPA P62937 4 5 3 4 23 18.012 165 2.1145 3 0.6245 5 
RBBP5 Q15291-1 6 7 6 7 17.1 63.303 573 7.2304 2 0.4485 5 
SAMD1 Q6SPF0 8 8 8 8 13.9 56.051 538 5.1117 6 0.3015 5 
BAF180 Q86U86-1 8 10 8 10 6.5 192.95 1689 2.1068 5 0.6228 5 
CTCF P49711 3 3 3 3 3.6 82.785 727 3.3665 4 0.1636 4 
RCC1 Q16269 4 3 4 3 11.1 48.145 452 2.3307 6 0.3352 4 
FEN1 P39748 4 3 4 3 9.2 42.592 380 1.7766 4 0.3441 4 
GLYR1 Q49A26-1 4 4 4 4 10.1 60.556 553 1.7678 4 0.4382 4 
CGI-37 Q9Y221-1 2 2 2 2 13.3 20.462 180 1.9645 3 0.6161 3 
EIF2A P05198 2 2 2 2 8.6 36.112 315 1.8728 1 0.1305 3 
BZAP45 B4DLZ8 2 3 2 2 6 51.281 451 2.2579 2 0.5996 3 
BIG3 P61964 3 3 3 3 15.3 36.588 334 3.4671 4 0.2711 3 
BXDC1 Q9H7B2 3 3 3 3 13.4 35.582 306 1.8820 4 0.1162 3 
ASH2L Q9UBL3-1 5 3 5 3 12.3 68.722 628 2.8407 5 0.5975 3 
DFS70 O75475-1 3 4 2 3 8.5 60.103 530 1.9358 4 0.0581 3 
hCG_1811093 Q96AN2 4 5 4 5 10.7 55.673 522 9.1732 3 0.2341 3 
SAP130 Q9H0E3-2 2 2 2 2 1.9 113.97 1083 5.5375 1 0.6393 2 
GIG38 O00422 2 2 2 2 12.2 19.526 172 1.9946 2 0.5518 2 
SRPR P08240 2 2 2 2 3 69.81 638 1.8588 2 0.6246 2 
LIG3 P49916-1 2 2 2 2 3 112.91 1009 1.7615 2 0.4606 2 
HMG2 P26583 2 2 1 1 12 24.033 209 1.7286 2 0.5274 2 
RIG P62841 2 3 2 3 13.8 17.04 145 2.5875 2 0.1277 2 
KIAA0662 O75151 3 3 3 2 4.9 121.06 1099 4.3333 2 0.1540 2 
MIG10 P00558 4 3 4 3 14.9 44.614 417 1.9933 3 0.2479 2 
SMARCA4 B9EGQ8 3 4 3 4 4.3 189.45 1681 1.7334 2 0.3606 2 
WDR76 Q9H967 4 5 4 5 8.9 69.752 626 2.0364 4 0.6207 2 
C20orf158 Q9BTC0-4 2 6 2 6 3.5 243.87 2240 2.1987 2 0.3005 2 
EZR P15311 5 8 1 3 13.7 69.412 586 2.3783 1 0.6425 2 
OCR Q9Y657 2 2 2 2 13 29.6 262 2.4112 1 0.0821 1 
BANP Q8N9N5-1 3 2 3 2 8.5 56.484 519 4.8794 1 0.6173 1 
ZBP89 Q9UQR1 3 4 3 4 8.3 88.975 794 4.9128 2 0.2865 1 
PPP1CB P62140 4 6 1 2 17.4 37.186 327 4.3475 1 0.0738 1 
CIF150 Q6P1X5 2 1 2 1 1.3 136.97 1199 3.1018 1   0 
IWS1 Q96ST2-1 3 2 3 2 4 91.954 819 2.2656 3   0 
BPTF Q12830-1 1 3 1 3 1.1 338.26 3046   0   0 
BRD4 O60885-1 2 3 2 2 2.5 152.22 1362   0   0 
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